The Estée Lauder Companies Inc. (EL) 10-Q 5 May 15 2015 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 31, 2015	Apr. 28, 2015
Entity Registrant Name	ESTEE LAUDER COMPANIES INC
Entity Central Index Key	1001250
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-24
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Common Class A
Entity Common Stock, Shares Outstanding		230,852,244
Common Class B
Entity Common Stock, Shares Outstanding		147,546,137

CONSOLIDATED_STATEMENTS_OF_EAR

CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
CONSOLIDATED STATEMENTS OF EARNINGS
Net Sales	$2,580.50	$2,549.80	$8,256	$8,243.50
Cost of Sales	502.9	498.7	1,612.60	1,624.40
Gross Profit	2,077.60	2,051.10	6,643.40	6,619.10
Operating expenses
Selling, general and administrative	1,680.40	1,709.50	5,265.40	5,173.90
Restructuring and other charges				-2.2
Total operating expenses	1,680.40	1,709.50	5,265.40	5,171.70
Operating Income	397.2	341.6	1,378	1,447.40
Interest expense	15.2	15	45	44.2
Interest income and investment income, net	3.1	2.7	8.5	6
Earnings before Income Taxes	385.1	329.3	1,341.50	1,409.20
Provision for income taxes	112.4	115.6	401.9	458.5
Net Earnings	272.7	213.7	939.6	950.7
Net earnings attributable to noncontrolling interests	-0.6	-0.5	-3.7	-4.3
Net Earnings Attributable to The Estee Lauder Companies Inc.	$272.10	$213.20	$935.90	$946.40
Net earnings attributable to The Estee Lauder Companies Inc. per common share
Basic (in dollars per share)	$0.72	$0.55	$2.46	$2.44
Diluted (in dollars per share)	$0.71	$0.54	$2.42	$2.40
Weighted-average common shares outstanding
Basic (in shares)	378.5	385.8	380.1	387.3
Diluted (in shares)	384.7	392.1	386.3	394.1
Cash dividends declared per common share (in dollars per share)	$0.24	$0.20	$0.68	$0.58

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Net earnings	$272.70	$213.70	$939.60	$950.70
Other comprehensive income (loss):
Net unrealized investment gain (loss)	2.1	0.2	-0.7	0.6
Net derivative instrument gain (loss)	25	1.4	80.3	-14.2
Amounts included in net periodic benefit cost	10.1	5.5	23	16.3
Translation adjustments	-139.5	-8.2	-374.1	44.3
Benefit (provision) for deferred income taxes on components of other comprehensive income	-13.4	-2	-39.7	1.8
Total other comprehensive income (loss)	-115.7	-3.1	-311.2	48.8
Comprehensive income (loss)	157	210.6	628.4	999.5
Comprehensive (income) loss attributable to noncontrolling interests:
Net earnings	-0.6	-0.5	-3.7	-4.3
Translation adjustments	2.1	-0.1	2.6	-0.8
Total comprehensive (income) loss attributable to noncontrolling interests	1.5	-0.6	-1.1	-5.1
Comprehensive income attributable to The Estee Lauder Companies Inc.	$158.50	$210	$627.30	$994.40

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Jun. 30, 2014
In Millions, unless otherwise specified
Current Assets
Cash and cash equivalents	$1,288.30	$1,629.10
Short-term investments	136.7
Accounts receivable, net	1,350.20	1,379.30
Inventory and promotional merchandise, net	1,073.10	1,294
Prepaid expenses and other current assets	580.9	522.8
Total current assets	4,429.20	4,825.20
Property, Plant and Equipment, net	1,398.20	1,502.60
Other Assets
Long-term investments	393.7	13.6
Goodwill	1,147	893.2
Other intangible assets, net	330.4	157.3
Other assets	396.6	476.9
Total other assets	2,267.70	1,541
Total assets	8,095.10	7,868.80
Current Liabilities
Current debt	135.3	18.4
Accounts payable	497.7	524.5
Other accrued liabilities	1,464.40	1,513.80
Total current liabilities	2,097.40	2,056.70
Noncurrent Liabilities
Long-term debt	1,317.50	1,324.70
Other noncurrent liabilities	815.3	618
Total noncurrent liabilities	2,132.80	1,942.70
Contingencies (Note 8)
Equity
Common stock, $.01 par value; Class A shares authorized: 1,300,000,000 at March 31, 2015 and June 30, 2014; shares issued: 417,509,769 at March 31, 2015 and 412,590,913 at June 30, 2014; Class B shares authorized: 304,000,000 at March 31, 2015 and June 30, 2014; shares issued and outstanding: 147,546,137 at March 31, 2015 and 148,728,082 at June 30, 2014	5.7	5.6
Paid-in capital	2,816.70	2,562.70
Retained earnings	6,942.10	6,265.80
Accumulated other comprehensive loss	-408.9	-100.3
Stockholders' equity before treasury stock	9,355.60	8,733.80
Less: Treasury stock, at cost; 186,680,701 Class A shares at March 31, 2015 and 178,434,483 Class A shares at June 30, 2014	-5,500.50	-4,878.90
Total stockholders' equity - The Estee Lauder Companies Inc.	3,855.10	3,854.90
Noncontrolling interests	9.8	14.5
Total equity	3,864.90	3,869.40
Total liabilities and equity	$8,095.10	$7,868.80

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Common Class A
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	1,300,000,000	1,300,000,000
Common stock, shares issued	417,509,769	412,590,913
Treasury stock, shares	186,680,701	178,434,483
Common Class B
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	304,000,000	304,000,000
Common stock, shares issued	147,546,137	148,728,082
Common stock, shares outstanding	147,546,137	148,728,082

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash Flows from Operating Activities
Net earnings	$939.60	$950.70
Adjustments to reconcile net earnings to net cash flows from operating activities:
Depreciation and amortization	298.6	280
Deferred income taxes	-56.2	-33.7
Non-cash stock-based compensation	133.9	124.8
Excess tax benefits from stock-based compensation arrangements	-40.7	-31.9
Loss on disposal of property, plant and equipment	8.1	7.6
Non-cash charges associated with restructuring charges		0.1
Pension and post-retirement benefit expense	48.3	52.6
Pension and post-retirement benefit contributions	-18.5	-22.7
Loss on Venezuela remeasurement	5.3	38.3
Change in fair value of contingent consideration	4.1
Other non-cash items	-4.4	-0.2
Changes in operating assets and liabilities:
Increase in accounts receivable, net	-94.2	-226.7
Decrease (increase) in inventory and promotional merchandise, net	104.9	-87.4
Increase in other assets, net	-14.4	-65.1
Increase in accounts payable	14.8	26.4
Increase in other accrued and noncurrent liabilities	55.8	156.6
Net cash flows provided by operating activities	1,385	1,169.40
Cash Flows from Investing Activities
Capital expenditures	-279.8	-342.8
Acquisition of businesses and other intangible assets, net of cash acquired	-242	-9.2
Proceeds from disposition of investments	181.3	8.4
Purchases of investments	-691.7	-0.6
Net cash flows used for investing activities	-1,032.20	-344.2
Cash Flows from Financing Activities
Proceeds from current debt, net	118.7	5.3
Debt issuance costs	-1.1
Repayments and redemptions of long-term debt	-6	-9.1
Net proceeds from stock-based compensation transactions	83.5	55.4
Excess tax benefits from stock-based compensation arrangements	40.7	31.9
Payments to acquire treasury stock	-626.1	-600.3
Dividends paid to stockholders	-259.8	-225.2
Payments to noncontrolling interest holders for dividends	-4.3	-2.7
Net cash flows used for financing activities	-654.4	-744.7
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-39.2	-46
Net Increase (Decrease) in Cash and Cash Equivalents	-340.8	34.5
Cash and Cash Equivalents at Beginning of Period	1,629.10	1,495.70
Cash and Cash Equivalents at End of Period	$1,288.30	$1,530.20

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	NOTE 1 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”).  All significant intercompany balances and transactions have been eliminated.
	Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation.
	The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year.  The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.
	Management Estimates
	The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements.  Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, pension and other post-retirement benefit costs, goodwill, other intangible assets and long-lived assets, and income taxes.  Descriptions of these policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.  Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate.  As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions.  Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.
	Currency Translation and Transactions
	All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at weighted-average rates of exchange for the period.  Unrealized translation gains (losses) reported as cumulative translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. amounted to $(144.4) million and $(7.6) million, net of tax, during the three months ended March 31, 2015 and 2014, respectively, and $(392.5) million and $50.4 million, net of tax, during the nine months ended March 31, 2015 and 2014, respectively.
	For the Company’s Venezuelan subsidiary operating in a highly inflationary economy, the U.S. dollar is the functional currency.  Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings.  During the third quarter of fiscal 2014, the Venezuelan government enacted changes to the foreign exchange controls that expanded the use of its then-existing exchange mechanisms and created another exchange control mechanism (“SICAD II”), which allowed companies to apply for the purchase of foreign currency and foreign currency denominated securities for any legal use or purpose.  The Company considered its specific facts and circumstances in determining the appropriate remeasurment rate and determined the SICAD II rate was the most appropriate rate that reflected the economics of its Venezuelan subsidiary’s business as of March 24, 2014, when the SICAD II mechanism became operational.  As a result, the Company changed the exchange rate used to remeasure the monetary assets and liabilities of its Venezuelan subsidiary from 6.3 to the SICAD II rate, which was 49.81 as of March 31, 2014.  Accordingly, a remeasurement charge of $38.3 million, on a before and after tax basis, was reflected in Selling, general and administrative expenses in the Company’s consolidated statements of earnings for the three and nine months ended March 31, 2014.
	On February 12, 2015, the Venezuelan government introduced a new open market foreign exchange system (“SIMADI”), which effectively replaced the SICAD II mechanism.  As the SIMADI is the only mechanism legally available at this time for the Company’s highest priority transactions, which are the import of goods, the Company changed the exchange rate used to remeasure the monetary assets and liabilities of its Venezuelan subsidiary to the SIMADI rate, which was 191.97 as of March 31, 2015.  Accordingly, a remeasurement charge of $5.3 million, on a before and after tax basis, was reflected in Selling, general and administrative expenses in the Company’s consolidated statements of earnings for the three and nine months ended March 31, 2015. The net monetary assets of the Company’s Venezuelan subsidiary were not material at March 31, 2015.
	The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures.  Accordingly, the Company categorizes these instruments as entered into for purposes other than trading.
	The accompanying consolidated statements of earnings include net exchange gains (losses) on foreign currency transactions, including the effects of Venezuelan remeasurement charges, of $7.2 million and $(41.7) million during the three months ended March 31, 2015 and 2014, respectively, and $(9.2) million and $(48.1) million during the nine months ended March 31, 2015 and 2014, respectively.
	Accounts Receivable
	Accounts receivable is stated net of the allowance for doubtful accounts and customer deductions totaling $20.7 million and $23.9 million as of March 31, 2015 and June 30, 2014, respectively.
	Concentration of Credit Risk
	The Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products.  The Company’s sales subject to credit risk are made primarily to department stores, perfumeries, specialty multi-brand retailers and retailers in its travel retail business.  The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk.
	The Company’s largest customer sells products primarily within the United States and accounted for $268.6 million, or 10%, and $284.0 million, or 11%, of the Company’s consolidated net sales for the three months ended March 31, 2015 and 2014, respectively, and $827.4 million, or 10%, and $907.0 million, or 11%, of the Company’s consolidated net sales for the nine months ended March 31, 2015 and 2014, respectively.  This customer accounted for $199.7 million, or 15%, and $158.5 million, or 11%, of the Company’s accounts receivable at March 31, 2015 and June 30, 2014, respectively.
	Inventory and Promotional Merchandise
	Inventory and promotional merchandise, net consists of:
		March 31		June 30
	(In millions)	2015		2014
	Raw materials	$	254.5	$	317.5
	Work in process	133.3		192.4
	Finished goods	551.2		599.5
	Promotional merchandise	134.1		184.6
		$	1,073.1	$	1,294.0
	Property, Plant and Equipment
		March 31		June 30
	(In millions)	2015		2014
	Assets (Useful Life)
	Land	$	14.9	$	15.4
	Buildings and improvements (10 to 40 years)	195.5		205.0
	Machinery and equipment (3 to 10 years)	642.1		673.9
	Computer hardware and software (4 to 10 years)	985.0		994.8
	Furniture and fixtures (5 to 10 years)	68.0		75.1
	Leasehold improvements	1,534.5		1,565.7
		3,440.0		3,529.9
	Less accumulated depreciation and amortization	2,041.8		2,027.3
		$	1,398.2	$	1,502.6
	The cost of assets related to projects in progress of $156.8 million and $229.9 million as of March 31, 2015 and June 30, 2014, respectively, is included in their respective asset categories above.  Depreciation and amortization of property, plant and equipment was $97.2 million and $94.0 million during the three months ended March 31, 2015 and 2014, respectively, and $292.3 million and $275.1 million during the nine months ended March 31, 2015 and 2014, respectively.  Depreciation and amortization related to the Company’s manufacturing process is included in Cost of Sales, and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings.
	Other Accrued Liabilities
	Other accrued liabilities consist of the following:
		March 31		June 30
	(In millions)	2015		2014
	Advertising, merchandising and sampling	$	305.7	$	301.7
	Employee compensation	384.6		468.2
	Payroll and other taxes	155.0		161.2
	Accrued income taxes	147.9		113.6
	Other	471.2		469.1
		$	1,464.4	$	1,513.8
	Income Taxes
	The effective rate for income taxes was 29.2% and 35.1% for the three months ended March 31, 2015 and 2014, respectively.  The decrease in the effective income tax rate was primarily attributable to a reduction in the effective tax rate on the Company’s foreign operations, partially offset by an increase in income tax reserve adjustments. Contributing to a higher effective tax rate in the prior-year period was the impact of the Venezuelan remeasurement charge for which no tax benefit was provided.
	The effective rate for income taxes was 30.0% and 32.5% for the nine months ended March 31, 2015 and 2014, respectively.  The decrease in the effective income tax rate was primarily attributable to a reduction in the effective tax rate on the Company’s foreign operations, partially offset by an increase in income tax reserve adjustments.  Contributing to a higher effective tax rate in the prior-year period was the impact of the Venezuelan remeasurement charge for which no tax benefit was provided.
	As of March 31, 2015 and June 30, 2014, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $75.1 million and $58.1 million, respectively.  The total amount of unrecognized tax benefits at March 31, 2015 that, if recognized, would affect the effective tax rate was $51.6 million.  The total gross interest and penalties accrued related to unrecognized tax benefits during the three and nine months ended March 31, 2015 in the accompanying consolidated statements of earnings was $0.9 million and $5.7 million, respectively.  The total gross accrued interest and penalties in the accompanying consolidated balance sheets at March 31, 2015 and June 30, 2014 was $16.7 million and $12.5 million, respectively.  On the basis of the information available as of March 31, 2015, the Company does not expect any significant changes to the total amount of unrecognized tax benefits within the next 12 months.
	During the nine months ended March 31, 2015, the Company formally concluded the compliance process with respect to fiscal 2013 under the U.S. Internal Revenue Service Compliance Assurance Program.  The conclusion of this process did not impact the Company’s consolidated financial statements.
	As of March 31, 2015 and June 30, 2014, the Company had current net deferred tax assets of $262.3 million and $295.1 million, respectively, substantially all of which are included in Prepaid expenses and other current assets in the accompanying consolidated balance sheets.  In addition, the Company had noncurrent net deferred tax assets of $76.4 million and $85.5 million as of March 31, 2015 and June 30, 2014, respectively, substantially all of which are included in Other assets in the accompanying consolidated balance sheets.
	Recently Adopted Accounting Standards
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance that requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carryforward, a similar tax loss, or a tax credit carryforward.  If either (i) an NOL carryforward, a similar tax loss, or tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position or (ii) the entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice), an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset.  This guidance became effective for unrecognized tax benefits that existed as of the Company’s fiscal 2015 first quarter.  The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
	In March 2013, the FASB issued authoritative guidance to resolve the diversity in practice concerning the release of the cumulative translation adjustment (“CTA”) into net income (i) when a parent sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity, and (ii) in connection with a step acquisition of a foreign entity.  This amended guidance requires that CTA be released in net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, and that a pro rata portion of the CTA be released into net income upon a partial sale of an equity method investment in a foreign entity only.  In addition, the amended guidance clarifies the definition of a sale of an investment in a foreign entity to include both, events that result in the loss of a controlling financial interest in a foreign entity and events that result in an acquirer obtaining control of an acquiree in which it held an equity interest immediately prior to the date of acquisition.  The CTA should be released into net income upon the occurrence of such events.  This guidance became effective prospectively for the Company’s fiscal 2015 first quarter.  The adoption of this guidance did not have an impact on the Company’s consolidated financial statements.
	Recently Issued Accounting Standards
	In April 2015, the FASB issued authoritative guidance that simplifies the presentation of debt issuance costs.  Under the revised guidance, entities would no longer be able to recognize debt issuance costs as an asset in the balance sheet.  The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update.  This guidance becomes effective for the Company’s fiscal 2017 first quarter.  Early adoption is only permitted for financial statements that have not been previously issued.  Upon adoption, a reporting entity is required to apply the new guidance on a retrospective basis and required to comply with the applicable disclosures for a change in an accounting principle.  The Company will apply this new guidance retrospectively when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements.
	In April 2015, the FASB issued authoritative guidance to clarify the accounting treatment for fees paid by a customer in cloud computing arrangements.  Under the revised guidance, if a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses.  If the cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract.  The revised guidance will not change a customer’s accounting for service contracts. The guidance becomes effective for the Company’s fiscal 2017 first quarter, with early adoption permitted.  Upon adoption, a reporting entity can elect to apply the new guidance prospectively after the effective date, or retrospectively.  The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements.
In June 2014, the FASB amended its authoritative guidance on accounting for certain share-based payment awards.  The amended guidance requires that if share-based compensation awards have terms of a performance target that affect vesting and that could be achieved after the requisite service period, such performance target should be treated as a performance condition.  As such, the performance target should not be reflected in estimating the grant-date fair value of the award and compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved.  This guidance becomes effective for the Company’s fiscal 2017 first quarter, with early adoption permitted.  The guidance will permit an entity to apply the amendments in the update either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the consolidated financial statements and to all new or modified awards thereafter.  The Company will apply this new guidance when it becomes effective, and is currently evaluating the impact of adoption on its consolidated financial statements.
In May 2014, the FASB issued authoritative guidance that defines how companies should report revenues from contracts with customers.  The standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  It provides companies with a single comprehensive five-step principles-based model to use in accounting for revenue and supersedes current revenue recognition requirements, including most industry-specific and transaction-specific revenue guidance.  This guidance becomes effective for the Company’s fiscal 2018 first quarter, and early adoption is not permitted.  In April 2015, the FASB proposed a deferral of the effective date of the new revenue standard by one year.  The proposal will be subject to the FASB’s due process requirements, which include a period for public comments.  If the proposed deferral is passed, the new standard would not be effective for the Company until fiscal 2019.  The guidance permits an entity to apply the standard retrospectively to all prior periods presented, with certain practical expedients, or apply the requirements in the year of adoption, through a cumulative adjustment.  The Company will apply this new guidance when it becomes effective and has not yet selected a transition method.  The Company is currently evaluating the impact of adoption on its consolidated financial statements.
In April 2014, the FASB issued authoritative guidance which changes the criteria for a disposal to qualify as a discontinued operation.  This revised standard defines a discontinued operation as (i) a component of an entity or group of components that has been disposed of or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (ii) an acquired business or nonprofit activity that is classified as held for sale on the date of acquisition.  The standard also requires expanded disclosures related to discontinued operations and added disclosure requirements for individually material disposal transactions that do not meet the discontinued operations criteria.  This guidance becomes effective prospectively for the Company’s fiscal 2016 first quarter, with early adoption permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available to be issued.  The Company will apply this new guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements.

INVESTMENTS

INVESTMENTS	9 Months Ended
	Mar. 31, 2015
INVESTMENTS
INVESTMENTS
	NOTE 2 — INVESTMENTS
	During the fiscal 2015 second quarter, the Company modified its cash investment strategy to invest a portion of its cash and cash equivalents in short- and long-term investments.  The Company’s investment objectives include capital preservation, maintaining adequate liquidity, asset diversification, and achieving appropriate returns within the guidelines set forth in the Company’s investment policy.  These investments are classified as available-for-sale, with any temporary difference between the cost and fair value of an investment presented as a separate component of accumulated other comprehensive income (loss) (“AOCI”).  See Note 6 — Fair Value Measurements for further information about how the fair value of investments are determined.
	Investments in privately-held companies in which the Company has significant influence, but less than a controlling financial interest, are generally accounted for under the equity method of accounting.  These investments were not material to the Company’s consolidated financial statements as of March 31, 2015 and June 30, 2014 and are included in Long-term investments in the accompanying consolidated balance sheets.
	The Company evaluates investments held in unrealized loss positions for other-than-temporary impairment on a quarterly basis.  Such evaluation involves a variety of considerations, including assessments of the risks and uncertainties associated with general economic conditions and distinct conditions affecting specific issuers.  Factors considered by the Company include, but are not limited to (i) the length of time and extent the security has been in a material loss position; (ii) the financial condition and creditworthiness of the issuer; (iii) future economic conditions and market forecasts related to the issuer’s industry, sector, or geography; (iv) the Company’s intent and ability to retain its investment until maturity or for a period of time sufficient to allow for recovery of market value; and (v) an assessment of whether it is more likely than not that the Company will be required to sell its investment before recovery of market value.
	Gains and losses recorded in AOCI related to the Company’s available-for-sale investments as of March 31, 2015 were as follows:
	(In millions)	Cost			Gross			Gross			Fair Value
					Unrealized			Unrealized
					Gains			Losses
	U.S. government and agency securities	$	292.7		$	0.2		$	(0.1	)	$	292.8
	Foreign government and agency securities	20.5			—			—			20.5
	Corporate notes and bonds	166.7			0.2			(0.1		)	166.8
	Time deposits	12.9			—			—			12.9
	Other securities	30.2			1.2			—			31.4
	Total	$	523		$	1.6		$	(0.2	)	$	524.4
	Gross unrealized investment gains recorded in AOCI related to the Company’s available-for-sale investments as of June 30, 2014 were $2.1 million.
	The following table presents the Company’s available-for-sale securities by contractual maturity as of March 31, 2015:
	(In millions)	Cost			Fair Value
	Due within one year	$	136.7		$	136.7
	Due after one through five years	386.3			387.7
		$	523.0		$	524.4
	The following table presents the fair market value of the Company’s investments with gross unrealized losses that are not deemed to be other-than temporarily impaired as of March 31, 2015:
		In a Loss Position for Less Than 12						In a Loss Position for More Than 12
		Months						Months
	(In millions)	Fair Value			Gross Unrealized			Fair Value			Gross Unrealized
					Losses						Losses
	Available-for-sale securities	$	291.2		$	(0.2	)	$	—		$	—
	Gross gains and losses realized on sales of investments included in the consolidated statements of earnings were as follows:
		Three Months Ended March 31						Nine Months Ended March 31
	(In millions)	2015			2014			2015			2014
	Gross realized gains	$	0.1		$	—		$	1.6		$	—
	Gross realized losses	(0.1		)	—			(0.1		)	—
	Total	$	—		$	—		$	1.5		$	—
	The Company utilizes the first-in, first-out method to determine the cost of the security sold.

ACQUISITION_OF_BUSINESSES

ACQUISITION OF BUSINESSES	9 Months Ended
	Mar. 31, 2015
AQUISITION OF BUSINESSES
ACQUISITION OF BUSINESSES
	NOTE 3 — ACQUISITION OF BUSINESSES
	The Company acquired Le Labo, a fragrance brand, in November 2014, RODIN olio lusso, a skin care brand, in October 2014 and in January 2015, Editions de Parfums Frédéric Malle, a fragrance brand, and GLAMGLOW, a skin care brand.  The results of operations of these businesses are included in the accompanying consolidated financial statements commencing with the date they were acquired.  The purchase price related to each of these acquisitions includes cash paid at closing plus additional amounts to be paid in the future, a portion of which is contingent on the achievement of certain future operating results. The amounts paid at closing were funded by cash on hand and through the issuance of commercial paper.  The additional amounts are expected to be paid from fiscal 2018 through fiscal 2020 with the exception of working capital adjustments, which are anticipated to be settled during fiscal 2015.  The aggregate acquisition-date fair value of these transactions was approximately $445 million.  The purchase prices recorded are provisional pending final working capital adjustments and completion of the final valuations.
	These fiscal 2015 acquisitions were not material, individually or in the aggregate, to the Company’s consolidated financial statements.  Pro forma results of operations of the prior-year period have not been presented, as the impact on the Company’s consolidated financial results would not have been material.

GOODWILL_AND_OTHER_INTANGIBLE_

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2015
GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL AND OTHER INTANGIBLE ASSETS
	NOTE 4 — GOODWILL AND OTHER INTANGIBLE ASSETS
	During the nine months ended March 31, 2015, the Company acquired Le Labo, RODIN olio lusso, Editions de Parfums Frédéric Malle and GLAMGLOW, which included the addition of goodwill of $254.2 million, amortizable intangible assets of $27.5 million (with a weighted-average amortization period of approximately 9 years) and non-amortizable intangible assets of $157.2 million related to the Company’s fragrance and skin care product categories.  Approximately $159 million of goodwill recorded in connection with certain of these acquisitions is expected to be deductible for tax purposes.  During the nine months ended March 31, 2015, the Company recognized $7.2 million of goodwill associated with the continuing earn-out obligations related to the acquisition of the Bobbi Brown brand.
	The following table presents goodwill by product category and the related change in the carrying amount:
	(In millions)	Skin Care			Makeup			Fragrance			Hair Care			Total
	Balance as of June 30, 2014
	Goodwill	$	68.9		$	440.7		$	54.8		$	402.3		$	966.7
	Accumulated impairments	(33.6		)	—			—			(39.9		)	(73.5		)
		35.3			440.7			54.8			362.4			893.2
	Goodwill acquired during the period	121.2			7.2			133			—			261.4
	Translation adjustments	(0.6		)	(1.0		)	(2.0		)	(4.0		)	(7.6		)
		120.6			6.2			131			(4.0		)	253.8
	Balance as of March 31, 2015
	Goodwill	184.3			446.9			185.8			393.4			1,210.40
	Accumulated impairments	(28.4		)	—			—			(35.0		)	(63.4		)
		$	155.9		$	446.9		$	185.8		$	358.4		$	1,147.00
	Other intangible assets consist of the following:
		March 31, 2015									June 30, 2014
	(In millions)	Gross			Accumulated			Total Net			Gross			Accumulated			Total Net
		Carrying			Amortization			Book			Carrying			Amortization			Book
		Value						Value			Value						Value
	Amortizable intangible assets:
	Customer lists and other	$	293.7		$	225.0		$	68.7		$	268.3		$	216.7		$	51.6
	License agreements	43.0			43.0			—			43.0			43.0			—
		$	336.7		$	268.0		68.7			$	311.3		$	259.7		51.6
	Non-amortizable intangible assets:
	Trademarks and other							261.7									105.7
	Total intangible assets							$	330.4								$	157.3
	The aggregate amortization expense related to amortizable intangible assets was $3.6 million and $3.0 million for the three months ended March 31, 2015 and 2014, respectively, and was $9.7 million and $9.3 million for the nine months ended March 31, 2015 and 2014, respectively.  The estimated aggregate amortization expense for the remainder of fiscal 2015 and for each of fiscal 2016 to 2019 is $3.9 million, $15.2 million, $13.2 million, $11.7 million and $10.7 million, respectively.

DERIVATIVE_FINANCIAL_INSTRUMEN

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
	Mar. 31, 2015
DERIVATIVE FINANCIAL INSTRUMENTS
DERIVATIVE FINANCIAL INSTRUMENTS
	NOTE 5 — DERIVATIVE FINANCIAL INSTRUMENTS
	The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments.  The Company enters into foreign currency forward contracts and may enter into option contracts to reduce the effects of fluctuating foreign currency exchange rates and interest rate derivatives to manage the effects of interest rate movements on the Company’s aggregate liability portfolio.  The Company also enters into foreign currency forward contracts and may use option contracts, not designated as hedging instruments, to mitigate the change in fair value of specific assets and liabilities on the balance sheet.  The Company does not utilize derivative financial instruments for trading or speculative purposes.  Costs associated with entering into derivative financial instruments have not been material to the Company’s consolidated financial results.
	For each derivative contract entered into where the Company looks to obtain hedge accounting treatment, the Company formally and contemporaneously documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking the hedge transaction, the nature of the risk being hedged, how the hedging instruments’ effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method of measuring ineffectiveness.  This process includes linking all derivatives to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions.  The Company also formally assesses, both at the inception of the hedges and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.  If it is determined that a derivative is not highly effective, or that it has ceased to be a highly effective hedge, the Company will be required to discontinue hedge accounting with respect to that derivative prospectively.
	The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows:
			Asset Derivatives								Liability Derivatives
					Fair Value (1)								Fair Value (1)
	(In millions)		Balance Sheet		March 31			June 30			Balance Sheet		March 31			June 30
			Location		2015			2014			Location		2015			2014
	Derivatives Designated as Hedging Instruments:
	Foreign currency forward contracts		Prepaid expenses and other current assets		$	67.4		$	3.4		Other accrued liabilities		$	2.1		$	18.2
	Derivatives Not Designated as Hedging Instruments:
	Foreign currency forward contracts		Prepaid expenses and other current assets		3.6			0.8			Other accrued liabilities		13.3			0.9
	Total Derivatives				$	71.0		$	4.2				$	15.4		$	19.1
		-1		See Note 6 — Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined.
	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments are presented as follows:
			Amount of Gain or (Loss)						Location of Gain or		Amount of Gain or (Loss)
			Recognized in OCI on						(Loss) Reclassified		Reclassified from AOCI
			Derivatives						from AOCI into		into Earnings
			(Effective Portion)						Earnings		(Effective Portion) (1)
									(Effective Portion)
			Three Months Ended								Three Months Ended
			March 31								March 31
	(In millions)		2015			2014					2015			2014
	Derivatives in Cash-Flow Hedging Relationships:
	Foreign currency forward contracts		$	39.1		$	3.2		Cost of sales		$	3.6		$	1.1
									Selling, general and administrative		10.5			0.6
	Total derivatives		$	39.1		$	3.2				$	14.1		$	1.7
		-1		The amount of gain (loss) recognized in earnings related to the amount excluded from effectiveness testing was $(0.2) million and $0.3 million for the three months ended March 31, 2015 and 2014, respectively.  There was no gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships for the three months ended March 31, 2015 and 2014.
			Amount of Gain or (Loss)						Location of Gain or		Amount of Gain or (Loss)
			Recognized in OCI on						(Loss) Reclassified		Reclassified from AOCI
			Derivatives						from AOCI into		into Earnings
			(Effective Portion)						Earnings		(Effective Portion) (1)
									(Effective Portion)
			Nine Months Ended								Nine Months Ended
			March 31								March 31
	(In millions)		2015			2014					2015			2014
	Derivatives in Cash-Flow Hedging Relationships:
	Foreign currency forward contracts		$	103.2		$	(7.1	)	Cost of sales		$	5.4		$	3.6
									Selling, general and administrative		17.3			3.3
	Total derivatives		$	103.2		$	(7.1	)			$	22.7		$	6.9
		-1		The amount of gain (loss) recognized in earnings related to the amount excluded from effectiveness testing was $(1.0) million and $0.9 million for the nine months ended March 31, 2015 and 2014, respectively.  The amount of gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships was $0.6 million and $0.5 million for the nine months ended March 31, 2015 and 2014, respectively.
	The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows:
					Amount of Gain or (Loss)
					Recognized in Earnings on Derivatives
			Location of Gain or (Loss)		Three Months Ended						Nine Months Ended
			Recognized in Earnings on		March 31						March 31
	(In millions)		Derivatives		2015			2014			2015			2014
	Foreign currency forward contracts		Selling, general and administrative		$	(9.8	)	$	(2.3	)	$	(9.7	)	$	(0.9	)
	Foreign Currency Cash-Flow Hedges
	The Company enters into foreign currency forward contracts to hedge anticipated transactions, as well as receivables and payables denominated in foreign currencies, for periods consistent with the Company’s identified exposures.  The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on costs and on the cash flows that the Company receives from foreign subsidiaries.  The majority of foreign currency forward contracts are denominated in currencies of major industrial countries.  The Company may also enter into foreign currency option contracts to hedge anticipated transactions where there is a high probability that anticipated exposures will materialize.  The foreign currency forward contracts entered into to hedge anticipated transactions have been designated as foreign currency cash-flow hedges and have varying maturities through the end of March 2017.  Hedge effectiveness of foreign currency forward contracts is based on a hypothetical derivative methodology and excludes the portion of fair value attributable to the spot-forward difference which is recorded in current-period earnings.  Hedge effectiveness of foreign currency option contracts is based on a dollar offset methodology.
	The ineffective portion of both foreign currency forward and option contracts is recorded in current-period earnings.  For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses in AOCI are reclassified to earnings when the underlying forecasted transaction occurs.  If it is probable that the forecasted transaction will no longer occur, then any gains or losses in AOCI are reclassified to current-period earnings.  As of March 31, 2015, the Company’s foreign currency cash-flow hedges were highly effective in all material respects.  The estimated net gain as of March 31, 2015 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $32.6 million.  The accumulated gain (loss) on derivative instruments in AOCI was $68.0 million and $(12.5) million as of March 31, 2015 and June 30, 2014, respectively.
	At March 31, 2015, the Company had foreign currency forward contracts in the amount of $2,162.1 million.  The foreign currencies included in foreign currency forward contracts (notional value stated in U.S. dollars) are principally the British pound ($442.1 million), Euro ($333.4 million), Swiss franc ($307.7 million), Canadian dollar ($162.2 million), Hong Kong dollar ($148.8 million), Australian dollar ($140.8 million) and Japanese yen ($101.1 million).
	Fair-Value Hedges
	The Company may enter into interest rate derivative contracts to manage the exposure to interest rate fluctuations on its funded indebtedness and anticipated issuance of debt for periods consistent with the identified exposures.
	Credit Risk
	As a matter of policy, the Company enters into derivative contracts only with counterparties that have a long-term credit rating of at least A- or higher by at least two nationally recognized rating agencies.  The counterparties to these contracts are major financial institutions.  Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the gross fair value of contracts in asset positions, which totaled $71.0 million at March 31, 2015.  To manage this risk, the Company has established strict counterparty credit guidelines that are continually monitored.  Accordingly, management believes risk of loss under these hedging contracts is remote.
	Certain of the Company’s derivative financial instruments, with two counterparties, contain credit-risk-related contingent features.  At March 31, 2015, the Company was in a net asset position for certain derivative contracts that contain such features.  The fair value of those contracts as of March 31, 2015 was $19.2 million.  As of March 31, 2015, the Company was in compliance with such credit-risk-related contingent features.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2015
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS
	NOTE 6 — FAIR VALUE MEASUREMENTS
	The Company records certain of its financial assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date.  The accounting for fair value measurements must be applied to nonfinancial assets and nonfinancial liabilities that require initial measurement or remeasurement at fair value, which principally consist of assets and liabilities acquired through business combinations and goodwill, indefinite-lived intangible assets and long-lived assets for the purposes of calculating potential impairment.  The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The three levels of inputs that may be used to measure fair value are as follows:
	Level 1: Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date.
	Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
	Level 3: Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.  The inputs are unobservable in the market and significant to the instrument’s valuation.
	The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2015:
	(In millions)	Level 1		Level 2		Level 3			Total
	Assets:
	Foreign currency forward contracts	$	—	$	71.0	$	—		$	71.0
	Available-for-sale securities:
	U.S. government and agency securities	—		292.8		—			292.8
	Foreign government and agency securities	—		20.5		—			20.5
	Corporate notes and bonds	—		166.8		—			166.8
	Time deposits	—		12.9		—			12.9
	Other securities	6.7		24.7		—			31.4
	Total	$	6.7	$	588.7	$	—		$	595.4
	Liabilities:
	Foreign currency forward contracts	$	—	$	15.4	$	—		$	15.4
	Contingent consideration	—		—		160.7			160.7
	Total	$	—	$	15.4	$	160.7		$	176.1
	The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2014:
	(In millions)	Level 1		Level 2		Level 3			Total
	Assets:
	Foreign currency forward contracts	$	—	$	4.2	$	—		$	4.2
	Available-for-sale securities	7.6		—		—			7.6
	Total	$	7.6	$	4.2	$	—		$	11.8
	Liabilities:
	Foreign currency forward contracts	$	—	$	19.1	$	—		$	19.1
	The estimated fair values of the Company’s financial instruments are as follows:
		March 31				June 30
		2015				2014
	(In millions)	Carrying		Fair		Carrying			Fair
		Amount		Value		Amount			Value
	Nonderivatives
	Cash and cash equivalents	$	1,288.30	$	1,288.30	$	1,629.10		$	1,629.10
	Available-for-sale securities	524.4		524.4		7.6			7.6
	Note receivable	—		—		8.4			8.5
	Current and long-term debt	1,452.80		1,617.30		1,343.10			1,428.30
	Additional purchase price payable	36.9		36.9		—			—
	Contingent consideration	160.7		160.7		—			—
	Derivatives
	Foreign currency forward contracts, net — asset (liability)	55.6		55.6		(14.9		)	(14.9		)
	The following methods and assumptions were used to estimate the fair value of the Company’s other classes of financial instruments for which it is practicable to estimate that value:
	Cash and cash equivalents — Cash and all highly-liquid securities with original maturities of three months or less are classified as cash and cash equivalents, primarily consisting of cash deposits in interest bearing accounts, money market funds and time deposits. The carrying amount approximates fair value, primarily because of the short maturity of cash equivalent instruments.
	Available-for-sale securities — Available-for-sale securities classified within Level 1 of the valuation hierarchy are generally comprised of mutual funds and are valued using quoted market prices on an active exchange.  Available-for-sale securities classified within Level 2 of the valuation hierarchy are valued using third-party pricing services and for time deposits, the carrying amount approximates fair value. To determine fair value, the pricing services use market prices or prices derived from other observable market inputs such as benchmark curves, credit spreads, broker/dealer quotes, and other industry and economic factors.
	Note receivable — During the second quarter of fiscal 2013, the Company amended the agreement related to the August 2007 sale of Rodan + Fields (a brand then owned by the Company) to receive a fixed amount in lieu of future contingent consideration and other rights.  The fair value of the receivable under the amended agreement was determined by discounting the future cash flows using an implied market rate of 6.1%.  This implied market rate reflected the Company’s estimate of interest rates prevailing in the market for notes with comparable remaining maturities, the creditworthiness of the counterparty, and an assessment of the ultimate collectability of the instrument.  The implied market rate was deemed to be an unobservable input and as such the Company’s note receivable was classified within Level 3 of the valuation hierarchy as of June 30, 2014.  The remaining $8.4 million principal amount was received in August 2014.
	Foreign currency forward contracts — The fair values of the Company’s foreign currency forward contracts were determined using an industry-standard valuation model, which is based on an income approach.  The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from an independent pricing service.  To determine the fair value of contracts under the model, the difference between the contract price and the current forward rate was discounted using LIBOR for contracts with maturities up to 12 months, and swap yield curves for contracts with maturities greater than 12 months.
	Current and long-term debt — The fair value of the Company’s debt was estimated based on the current rates offered to the Company for debt with the same remaining maturities.  To a lesser extent, debt also includes capital lease obligations for which the carrying amount approximates the fair value.  The Company’s debt is classified within Level 2 of the valuation hierarchy.
	Additional purchase price payable — The Company’s additional purchase price payable represents fixed minimum additional purchase price that was discounted using the Company’s incremental borrowing rate, which was approximately 1%.  The additional purchase price payable is classified within Level 2 of the valuation hierarchy.
	Contingent Consideration — The fair value of the Company’s contingent consideration obligations is measured using Level 3 inputs which include a probability weighted-average cost of capital to discount estimated future cash flows based upon the likelihood of achieving certain future operating results. The fair value of the contingent consideration related to the acquisition earn-outs was determined by discounting the future cash flows using discount rates ranging from 9% to 14%.  These rates reflect the relative risk and probability of achieving future operating results with the potential earn-outs on the individual acquisitions.  These implied rates are deemed to be unobservable inputs and as such the Company’s contingent consideration is classified within Level 3 of the valuation hierarchy.  An increase or decrease in the risk premium of 100 basis points would result in a value that is approximately $6 million higher or lower than the current liability recorded.
	Changes in the fair value of the contingent consideration obligations for the nine months ended March 31, 2015 were as follows:
	(In millions)	Fair Value
	Contingent consideration at June 30, 2014	$	—
	Acquisitions	156.6
	Change in fair value	4.1
	Contingent consideration at March 31, 2015	$	160.7

PENSION_AND_POSTRETIREMENT_BEN

PENSION AND POST-RETIREMENT BENEFIT PLANS	9 Months Ended
	Mar. 31, 2015
PENSION AND POST-RETIREMENT BENEFIT PLANS
PENSION AND POST-RETIREMENT BENEFIT PLANS
	NOTE 7 — PENSION AND POST-RETIREMENT BENEFIT PLANS
	The Company maintains pension plans covering substantially all of its full-time employees for its U.S. operations and a majority of its international operations.  The Company also maintains post-retirement benefit plans which provide certain medical and dental benefits to eligible employees.  Descriptions of these plans are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.
	The components of net periodic benefit cost for the three months ended March 31, 2015 and 2014 consisted of the following:
														Other than
		Pension Plans												Pension Plans
		U.S.						International						Post-retirement
	(In millions)	2015			2014			2015			2014			2015			2014
	Service cost	$	8		$	7.9		$	5.7		$	6.2		$	0.8		$	0.8
	Interest cost	7.6			7.8			4.1			4.8			1.9			2
	Expected return on plan assets	(12.5		)	(11.7		)	(5.3		)	(5.2		)	(0.6		)	(0.5		)
	Amortization of:
	Prior service cost	0.1			0.1			0.5			0.7			0.2			0.3
	Actuarial loss	2.4			1.8			2.4			2.4			0.4			0.2
	Settlements and curtailments	—			—			(1.1		)	—			—			—
	Net periodic benefit cost	$	5.6		$	5.9		$	6.3		$	8.9		$	2.7		$	2.8
	The components of net periodic benefit cost for the nine months ended March 31, 2015 and 2014 consisted of the following:
														Other than
		Pension Plans												Pension Plans
		U.S.						International						Post-retirement
	(In millions)	2015			2014			2015			2014			2015			2014
	Service cost	$	23.8		$	23.7		$	18.2		$	18.5		$	2.5		$	2.5
	Interest cost	22.8			23.4			13.1			14.2			5.7			6
	Expected return on plan assets	(37.5		)	(35.1		)	(16.3		)	(15.4		)	(1.8		)	(1.5		)
	Amortization of:
	Prior service cost	0.4			0.5			1.6			2.1			0.6			0.7
	Actuarial loss	7.3			5.5			7.8			6.9			1.2			0.6
	Settlements and curtailments	—			—			(1.1		)	—			—			—
	Net periodic benefit cost	$	16.8		$	18		$	23.3		$	26.3		$	8.2		$	8.3
	During the nine months ended March 31, 2015, the Company made contributions to its international pension plans totaling approximately $10 million.
	The Company disclosed in its consolidated financial statements for the fiscal year ended June 30, 2014 that it did not expect to make cash contributions to its domestic trust based, noncontributory qualified defined benefit pension plan (“U.S. Qualified Plan”) during the fiscal year ending June 30, 2015.  As part of its ongoing review of funded levels, the Company made a discretionary contribution of $25.0 million to the U.S. Qualified Plan in April 2015.
	The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following:
		March 31			June 30
	(In millions)	2015			2014
	Other assets	$	127.2		$	135.2
	Other accrued liabilities	(26.9		)	(26.9		)
	Other noncurrent liabilities	(358.8		)	(380.5		)
	Funded status	(258.5		)	(272.2		)
	Accumulated other comprehensive loss	294.2			338.2
	Net amount recognized	$	35.7		$	66

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Mar. 31, 2015
CONTINGENCIES
CONTINGENCIES
	NOTE 8 — CONTINGENCIES
	Legal Proceedings
	The Company is involved, from time to time, in litigation and other legal proceedings incidental to its business.  Management believes that the outcome of current litigation and legal proceedings will not have a material adverse effect upon the Company’s results of operations, financial condition or cash flows.  However, management’s assessment of the Company’s current litigation and other legal proceedings could change in light of the discovery of facts with respect to legal actions or other proceedings pending against the Company not presently known to the Company or determinations by judges, juries or other finders of fact which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or proceedings.  Reasonably possible losses in addition to the amounts accrued for litigation and other legal proceedings are not material to the Company’s consolidated financial statements.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Mar. 31, 2015
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION
	NOTE 9 — STOCK-BASED COMPENSATION
	The Company has various stock-based compensation programs (the “Plans”) under which awards, including stock options, performance share units (“PSU”), restricted stock units (“RSU”), market share units (“MSU”), performance share units based on total stockholder return, and share units, may be granted.  As of March 31, 2015, approximately 11,067,200 shares of the Company’s Class A Common Stock were reserved and available to be granted pursuant to these Plans.
	Total net stock-based compensation expense is attributable to the granting of, and the remaining requisite service periods of stock options, PSUs, RSUs, MSUs, performance share units based on total stockholder return, and share units.  Compensation expense attributable to net stock-based compensation is as follows:
			Three Months Ended						Nine Months Ended
			March 31						March 31
	(In millions)		2015			2014			2015			2014
	Compensation expense		$	33.0		$	29.9		$	133.9		$	124.8
	Income tax benefit		10.9			9.9			43.9			41.0
	As of March 31, 2015, the total unrecognized compensation cost related to unvested stock-based awards was $138.9 million and the related weighted-average period over which it is expected to be recognized is approximately 2 years.
	Stock Options
	The following is a summary of the Company’s stock option programs as of March 31, 2015 and changes during the nine months then ended:
	(Shares in thousands)		Shares		Weighted-			Aggregate			Weighted-
					Average			Intrinsic			Average
					Exercise			Value (1)			Contractual Life
					Price Per			(in millions)			Remaining in
					Share						Years
	Outstanding at June 30, 2014		14,127.80		$	41.51
	Granted at fair value		2,172.00		76.12
	Exercised		(2,219.8	)	37.62
	Expired		(21.6	)	36.97
	Forfeited		(89.4	)	65.02
	Outstanding at March 31, 2015		13,969.00		47.36			$	500.1		6.4
	Vested and expected to vest at March 31, 2015		13,845.40		47.15			$	498.6		6.4
	Exercisable at March 31, 2015		9,653.00		37.37			$	442		5.5
		-1		The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
	The following is a summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised:
			Three Months Ended						Nine Months Ended
			March 31						March 31
	(In millions, except per share data)		2015			2014			2015			2014
	Per-share weighted-average grant date fair value of stock options granted		$	19.58		$	23.58		$	22.46		$	23.13
	Intrinsic value of stock options exercised		$	57.0		$	21.7		$	88.9		$	69.8
	The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
			Three Months Ended				Nine Months Ended
			March 31				March 31
			2015		2014		2015		2014
	Weighted-average expected stock-price volatility		27%		32%		28%		33%
	Weighted-average expected option life		7 years		7 years		7 years		7 years
	Average risk-free interest rate		1.60%		2.20%		2.20%		2.50%
	Average dividend yield		1.10%		1.10%		1.10%		1.10%
	The Company uses a weighted-average expected stock-price volatility assumption that is a combination of both current and historical implied volatilities of the underlying stock.  The implied volatilities were obtained from publicly available data sources.  For the weighted-average expected option life assumption, the Company considers the exercise behavior of past grants and models the pattern of aggregate exercises.  The average risk-free interest rate is based on the U.S. Treasury strip rate for the expected term of the options and the average dividend yield is based on historical experience.
	Performance Share Units
	During the nine months ended March 31, 2015, the Company granted approximately 261,700 PSUs, which will be settled in stock subject to the achievement of the Company’s net sales, diluted net earnings per common share and return on invested capital goals for the three fiscal years ending June 30, 2017, all subject to the continued employment or retirement of the grantees.  PSUs granted in fiscal 2015 are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSU.  In September 2014, approximately 377,300 shares of the Company’s Class A Common Stock were issued and related accrued dividends were paid, relative to the target goals set at the time of the PSU issuance, in settlement of approximately 259,700 PSUs that vested as of June 30, 2014.
	The following is a summary of the status of the Company’s PSUs as of March 31, 2015 and activity during the nine months then ended:
					Weighted-Average
					Grant Date
	(Shares in thousands)		Shares		Fair Value Per Share
	Nonvested at June 30, 2014		538.6		$	63.53
	Granted		261.7		76.23
	Vested		—		—
	Forfeited		—		—
	Nonvested at March 31, 2015		800.3		67.68
	Restricted Stock Units
	The Company granted approximately 1,431,000 RSUs during the nine months ended March 31, 2015 which, at the time of grant, were scheduled to vest as follows: 501,700 in fiscal 2016, 517,600 in fiscal 2017 and 411,700 in fiscal 2018.  All RSUs are subject to the continued employment or retirement of the grantees.  The RSUs granted in fiscal 2015 are accompanied by dividend equivalent rights, payable upon settlement of the RSU either in cash or shares (based on the terms of the particular award) upon settlement of the RSU and, as such, were valued at the closing market price of the Company’s Class A Common Stock on the date of grant.
	The following is a summary of the status of the Company’s RSUs as of March 31, 2015 and activity during the nine months then ended:
					Weighted-Average
					Grant Date
	(Shares in thousands)		Shares		Fair Value Per Share
	Nonvested at June 30, 2014		2,222.10		$	62.21
	Granted		1,431.00		76.14
	Dividend equivalents		7.4		76.06
	Vested		(948.1	)	60.76
	Forfeited		(63.7	)	67.62
	Nonvested at March 31, 2015		2,648.70		70.17
Performance Share Units Based on Total Stockholder Return
During fiscal 2013, the Company granted PSUs to an executive of the Company with an aggregate target payout of 162,760 shares of the Company’s Class A Common Stock, subject to continued employment through the end of the relative performance periods, which end June 30, 2015, 2016 and 2017.  Such PSUs will be settled based upon the Company’s relative total stockholder return (“TSR”) over the relevant performance period as compared to companies in the S&P 500 on July 1, 2012.  No settlement will occur if the Company’s TSR falls below a minimum threshold, and up to an aggregate of 260,416 shares of the Company’s Class A Common Stock will be issued depending on the extent to which the Company’s TSR equals or exceeds the minimum threshold.  The PSUs are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSU.
The grant date fair value of the PSUs of $11.0 million was estimated using a lattice model with a Monte Carlo simulation and the following assumptions for each performance period, respectively: contractual life of 33, 45 and 57 months, average risk-free interest rate of 0.3%, 0.5% and 0.7% and a dividend yield of 1.0%.  Using the historical stock prices and dividends from public sources, the Company estimated the covariance structure of the returns on S&P 500 stocks.  The volatility for the Company’s stock produced by this estimation was 32%.  The average risk-free interest rate is based on the U.S. Treasury strip rates over the contractual term of the grant and the dividend yield is based on historical experience.
Market Share Unit
The Company had one outstanding market share unit, which vested on June 30, 2014.  The market share unit had a grant date fair value of $10.6 million that was estimated using a lattice model with a Monte Carlo simulation and the following assumptions: contractual life of 41 months, a weighted-average expected volatility of 29%, a weighted-average risk-free interest rate of 1.6% and a weighted-average dividend yield of 1.0%.  The Company used an expected stock-price volatility assumption that is a combination of both current and historical implied volatilities from options on the underlying stock.  The implied volatilities were obtained from publicly available data sources.  The expected life was equal to the contractual term of the grant.  The average risk-free interest rate was based on the U.S. Treasury strip rates over the contractual term of the grant and the average dividend yield was based on historical experience.  In accordance with the terms of the grant, 320,000 shares of the Company’s Class A Common Stock were issued, and related dividends were paid.  The number of shares equaled the maximum payout under the award, because the average closing stock price per share of the Company’s Class A Common Stock on the New York Stock Exchange during the last 20 trading days ending on June 30, 2014 exceeded $75.00 per share.
Share Units
The Company grants share units to certain non-employee directors under the Non-Employee Director Share Incentive Plan.  The following is a summary of the status of the Company’s share units as of March 31, 2015 and activity during the nine months then ended:
				Weighted-Average
				Grant Date
(Shares in thousands)		Shares		Fair Value Per Share
Outstanding at June 30, 2014		98.8		$	37.67
Granted		10.2		71.33
Dividend equivalents		1.0		75.88
Converted		—		—
Outstanding at March 31, 2015		110.0		41.12
Cash Units
Certain non-employee directors defer cash compensation in the form of cash payout share units, which are not subject to the Plans.  These share units are classified as liabilities and, as such, their fair value is adjusted to reflect the current market value of the Company’s Class A Common Stock.  The Company recorded $1.7 million and $(1.6) million as compensation expense (income) to reflect additional deferrals and the change in the market value for the three months ended March 31, 2015 and 2014, respectively.  The Company recorded $2.5 million and $0.7 million as compensation expense to reflect additional deferrals and the change in the market value for the nine months ended March 31, 2015 and 2014, respectively.

NET_EARNINGS_ATTRIBUTABLE_TO_T

NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE	9 Months Ended
	Mar. 31, 2015
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE
	NOTE 10 — NET EARNINGS ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC. PER COMMON SHARE
	Net earnings attributable to The Estée Lauder Companies Inc. per common share (“basic EPS”) is computed by dividing net earnings attributable to The Estée Lauder Companies Inc. by the weighted-average number of common shares outstanding and contingently issuable shares (which satisfy certain conditions).  Net earnings attributable to The Estée Lauder Companies Inc. per common share assuming dilution (“diluted EPS”) is computed by reflecting potential dilution from stock-based awards.
	A reconciliation between the numerator and denominator of the basic and diluted EPS computations is as follows:
		Three Months Ended				Nine Months Ended
		March 31				March 31
	(In millions, except per share data)	2015		2014		2015		2014
	Numerator:
	Net earnings attributable to The Estée Lauder Companies Inc.	$	272.1	$	213.2	$	935.9	$	946.4
	Denominator:
	Weighted-average common shares outstanding — Basic	378.5		385.8		380.1		387.3
	Effect of dilutive stock options	4.6		4.8		4.6		5.0
	Effect of RSUs	1.6		1.2		1.6		1.4
	Effect of PSUs based on TSR	—		—		—		0.1
	Effect of MSU	—		0.3		—		0.3
	Weighted-average common shares outstanding — Diluted	384.7		392.1		386.3		394.1
	Net earnings attributable to The Estée Lauder Companies Inc. per common share:
	Basic	$	0.72	$	0.55	$	2.46	$	2.44
	Diluted	0.71		0.54		2.42		2.40
	As of March 31, 2015 and 2014, outstanding options to purchase 2.1 million and 1.8 million shares, respectively, of Class A Common Stock were not included in the computation of diluted EPS because their inclusion would be anti-dilutive.  As of March 31, 2015 and 2014, 0.8 million PSUs have been excluded from the calculation of diluted EPS because the number of shares ultimately issued is contingent on the achievement of certain performance targets of the Company, as discussed in Note 9 — Stock-Based Compensation.

EQUITY

EQUITY	9 Months Ended
	Mar. 31, 2015
EQUITY
EQUITY
	NOTE 11 — EQUITY
			Total Stockholders’ Equity — The Estée Lauder Companies Inc.																		Non-
	(In millions)		Common			Paid-in			Retained			AOCI			Treasury			Total			controlling			Total
			Stock			Capital			Earnings						Stock						Interests			Equity
	Balance at June 30, 2014		$	5.6		$	2,562.70		$	6,265.80		$	(100.3	)	$	(4,878.9	)	$	3,854.90		$	14.5		$	3,869.40
	Net earnings		—			—			935.9			—			—			935.9			3.7			939.6
	Common stock dividends		—			—			(259.6		)	—			—			(259.6		)	(5.8		)	(265.4		)
	Other comprehensive income (loss)		—			—			—			(308.6		)	—			(308.6		)	(2.6		)	(311.2		)
	Acquisition of treasury stock		—			—			—			—			(572.7		)	(572.7		)	—			(572.7		)
	Stock-based compensation		0.1			254			—			—			(48.9		)	205.2			—			205.2
	Balance at March 31, 2015		$	5.7		$	2,816.70		$	6,942.10		$	(408.9	)	$	(5,500.5	)	$	3,855.10		$	9.8		$	3,864.90
	The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the nine months ended March 31, 2015:
	Date Declared		Record Date		Payable Date		Amount per Share
	August 14, 2014		August 29, 2014		September 15, 2014		$	0.2
	November 3, 2014		November 28, 2014		December 15, 2014		$	0.24
	February 4, 2015		February 27, 2015		March 16, 2015		$	0.24
	On May 4, 2015, a quarterly dividend was declared in the amount of $.24 per share on the Company’s Class A and Class B Common Stock.  The dividend is payable in cash on June 15, 2015 to stockholders of record at the close of business on May 29, 2015.
	Common Stock
	During the nine months ended March 31, 2015, the Company purchased approximately 8.4 million shares of its Class A Common Stock for $626.1 million.
	During the nine months ended March 31, 2015, approximately 1.2 million shares of the Company’s Class B Common Stock were converted into the same amount of shares of the Company’s Class A Common Stock.
	Accumulated Other Comprehensive Income (Loss)
	The following table represents changes in AOCI, net of tax, by component for the nine months ended March 31, 2015:
	(In millions)		Net			Net			Amounts			Translation			Total
			Unrealized			Derivative			Included in			Adjustments
			Investment			Instrument			Net Periodic
			Gain (Loss)			Gain (Loss)			Benefit Cost
	Balance at June 30, 2014		$	1.4		$	(0.9	)	$	(233.0	)	$	132.2		$	(100.3	)
	OCI before reclassifications		0.6			66.6			20		-1	(392.5		)	(305.3		)
	Amounts reclassified from AOCI		(1.0		)	(14.8		)	12.5			—			(3.3		)
	Net current-period OCI		(0.4		)	51.8			32.5			(392.5		)	(308.6		)
	Balance at March 31, 2015		$	1		$	50.9		$	(200.5	)	$	(260.3	)	$	(408.9	)
		-1		Includes foreign currency translation gains of $21.0 million.
	The following table represents the effects of reclassification adjustments from AOCI into net earnings for the three and nine months ended March 31, 2015 and 2014:
			Amount Reclassified from AOCI
			Three Months Ended						Nine Months Ended						Affected Line Item in
			March 31						March 31						Consolidated
	(In millions)		2015			2014			2015			2014			Statement of Earnings
	Gain (Loss) on Available-For-Sale Securities
	Available-for-sale securities		$	—		$	—		$	1.5		$	—		Interest income and investment income, net
	Benefit (provision) for deferred taxes		(0.1		)	—			(0.5		)	—			Provision for income taxes
			$	(0.1	)	$	—		$	1		$	—		Net earnings
	Gain (Loss) on Cash-Flow Hedges
	Foreign currency forward contracts		$	3.6		$	1.1		$	5.4		$	3.6		Cost of sales
	Foreign currency forward contracts		10.5			0.6			17.3			3.3			Selling, general and administrative
			14.1			1.7			22.7			6.9			Earnings before income taxes
	Benefit (provision) for deferred taxes		(4.9		)	(0.5		)	(8.0		)	(2.3		)	Provision for income taxes
			$	9.2		$	1.2		$	14.7		$	4.6		Net earnings
	Gain (Loss) on Fair-Value Hedges
	Settled interest rate-related derivatives		$	—		$	0.1		$	0.2		$	0.2		Interest expense
	Benefit (provision) for deferred taxes		—			—			(0.1		)	(0.1		)	Provision for income taxes
			$	—		$	0.1		$	0.1		$	0.1		Net earnings
	Amounts Included in Net Periodic Benefit Cost
	Amortization of prior service cost		$	(0.8	)	$	(1.1	)	$	(2.6	)	$	(3.3	)(1)
	Amortization of actuarial loss		(5.2		)	(4.4		)	(16.3		)	(13.0		)(1)
	Settlements and curtailments		1.1			—			1.1			—		-1
			(4.9		)	(5.5		)	(17.8		)	(16.3		)	Earnings before income taxes
	Benefit (provision) for deferred taxes		1.5			1.6			5.3			4.7			Provision for income taxes
			$	(3.4	)	$	(3.9	)	$	(12.5	)	$	(11.6	)	Net earnings
	Total reclassification adjustments, net		$	5.7		$	(2.6	)	$	3.3		$	(6.9	)	Net earnings
		-1		See Note 7 — Pension and Post-Retirement Benefit Plans for additional information.

STATEMENT_OF_CASH_FLOWS

STATEMENT OF CASH FLOWS	9 Months Ended
	Mar. 31, 2015
STATEMENT OF CASH FLOWS
STATEMENT OF CASH FLOWS
	NOTE 12 — STATEMENT OF CASH FLOWS
	Supplemental cash flow information for the nine months ended March 31, 2015 and 2014 is as follows:
	(In millions)	2015			2014
	Cash:
	Cash paid during the period for interest	$	41.3		$	41.1
	Cash paid during the period for income taxes	$	317.6		$	357.6
	Non-cash investing and financing activities:
	Incremental tax benefit from the exercise of stock options	$	(8.6	)	$	(5.1	)
	Capital lease obligations incurred	$	7.6		$	12
	Accrued dividend distribution to noncontrolling interest	$	1.4		$	2.4

SEGMENT_DATA_AND_RELATED_INFOR

SEGMENT DATA AND RELATED INFORMATION	9 Months Ended
	Mar. 31, 2015
SEGMENT DATA AND RELATED INFORMATION
SEGMENT DATA AND RELATED INFORMATION
	NOTE 13 — SEGMENT DATA AND RELATED INFORMATION
	Reportable operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the “Chief Executive”) in deciding how to allocate resources and in assessing performance.  Although the Company operates in one business segment, beauty products, management also evaluates performance on a product category basis.  Product category performance is measured based upon net sales and earnings before income taxes, interest expense, interest income and investment income, net and total adjustments associated with restructuring activities.  Total adjustments associated with restructuring activities are not allocated to the product categories because they result from activities that are deemed part of a company-wide program to redesign the Company’s organizational structure.
	The accounting policies for the Company’s reportable segments are substantially the same as those for the consolidated financial statements, as described in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.  The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the Chief Executive or included herein.  There has been no significant variance in the total or long-lived asset values associated with the Company’s segment data since June 30, 2014.
		Three Months Ended						Nine Months Ended
		March 31						March 31
	(In millions)	2015			2014			2015			2014
	PRODUCT CATEGORY DATA
	Net Sales:
	Skin Care	$	1,101.00		$	1,132.10		$	3,466.80		$	3,564.40
	Makeup	1,082.50			1,015.70			3,280.00			3,145.80
	Fragrance	263.2			270.5			1,080.30			1,115.70
	Hair Care	125.6			120.8			390.8			380.7
	Other	8.2			10.7			38.1			36.8
		2,580.50			2,549.80			8,256.00			8,243.40
	Adjustments associated with restructuring activities	—			—			—			0.1
	Net Sales	$	2,580.50		$	2,549.80		$	8,256.00		$	8,243.50
	Operating Income (Loss) before total adjustments associated with restructuring activities:
	Skin Care	$	215.7		$	179		$	709.2		$	758.6
	Makeup	159.3			149.9			538.6			564.5
	Fragrance	17.5			(1.9		)	104			95.5
	Hair Care	7.1			13.2			32.1			29.3
	Other	(2.4		)	1.6			(5.9		)	(2.6		)
		397.2			341.8			1,378.00			1,445.30
	Reconciliation:
	Total adjustments associated with restructuring activities	—			(0.2		)	—			2.1
	Interest expense	(15.2		)	(15.0		)	(45.0		)	(44.2		)
	Interest income and investment income, net	3.1			2.7			8.5			6
	Earnings before income taxes	$	385.1		$	329.3		$	1,341.50		$	1,409.20
	GEOGRAPHIC DATA
	Net Sales:
	The Americas	$	1,109.90		$	1,072.00		$	3,426.10		$	3,469.00
	Europe, the Middle East & Africa	950.3			959.4			3,104.00			3,031.60
	Asia/Pacific	520.3			518.4			1,725.90			1,742.80
		2,580.50			2,549.80			8,256.00			8,243.40
	Adjustments associated with restructuring activities	—			—			—			0.1
	Net Sales	$	2,580.50		$	2,549.80		$	8,256.00		$	8,243.50
	Operating Income (Loss):
	The Americas	$	109.6		$	111.5		$	287.8		$	419.7
	Europe, the Middle East & Africa	204.3			160.2			729.4			673.4
	Asia/Pacific	83.3			70.1			360.8			352.2
		397.2			341.8			1,378.00			1,445.30
	Total adjustments associated with restructuring activities	—			(0.2		)	—			2.1
	Operating Income	$	397.2		$	341.6		$	1,378.00		$	1,447.40

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
	Basis of Presentation
	The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”).  All significant intercompany balances and transactions have been eliminated.
	Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation.
	The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included.  The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year.  The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.
Management Estimates
	Management Estimates
	The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements.  Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, pension and other post-retirement benefit costs, goodwill, other intangible assets and long-lived assets, and income taxes.  Descriptions of these policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014.  Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate.  As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions.  Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.
Currency Translation and Transactions
	Currency Translation and Transactions
	All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at weighted-average rates of exchange for the period.  Unrealized translation gains (losses) reported as cumulative translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. amounted to $(144.4) million and $(7.6) million, net of tax, during the three months ended March 31, 2015 and 2014, respectively, and $(392.5) million and $50.4 million, net of tax, during the nine months ended March 31, 2015 and 2014, respectively.
	For the Company’s Venezuelan subsidiary operating in a highly inflationary economy, the U.S. dollar is the functional currency.  Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings.  During the third quarter of fiscal 2014, the Venezuelan government enacted changes to the foreign exchange controls that expanded the use of its then-existing exchange mechanisms and created another exchange control mechanism (“SICAD II”), which allowed companies to apply for the purchase of foreign currency and foreign currency denominated securities for any legal use or purpose.  The Company considered its specific facts and circumstances in determining the appropriate remeasurment rate and determined the SICAD II rate was the most appropriate rate that reflected the economics of its Venezuelan subsidiary’s business as of March 24, 2014, when the SICAD II mechanism became operational.  As a result, the Company changed the exchange rate used to remeasure the monetary assets and liabilities of its Venezuelan subsidiary from 6.3 to the SICAD II rate, which was 49.81 as of March 31, 2014.  Accordingly, a remeasurement charge of $38.3 million, on a before and after tax basis, was reflected in Selling, general and administrative expenses in the Company’s consolidated statements of earnings for the three and nine months ended March 31, 2014.
	On February 12, 2015, the Venezuelan government introduced a new open market foreign exchange system (“SIMADI”), which effectively replaced the SICAD II mechanism.  As the SIMADI is the only mechanism legally available at this time for the Company’s highest priority transactions, which are the import of goods, the Company changed the exchange rate used to remeasure the monetary assets and liabilities of its Venezuelan subsidiary to the SIMADI rate, which was 191.97 as of March 31, 2015.  Accordingly, a remeasurement charge of $5.3 million, on a before and after tax basis, was reflected in Selling, general and administrative expenses in the Company’s consolidated statements of earnings for the three and nine months ended March 31, 2015. The net monetary assets of the Company’s Venezuelan subsidiary were not material at March 31, 2015.
	The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures.  Accordingly, the Company categorizes these instruments as entered into for purposes other than trading.
	The accompanying consolidated statements of earnings include net exchange gains (losses) on foreign currency transactions, including the effects of Venezuelan remeasurement charges, of $7.2 million and $(41.7) million during the three months ended March 31, 2015 and 2014, respectively, and $(9.2) million and $(48.1) million during the nine months ended March 31, 2015 and 2014, respectively.
Accounts Receivable
	Accounts Receivable
	Accounts receivable is stated net of the allowance for doubtful accounts and customer deductions totaling $20.7 million and $23.9 million as of March 31, 2015 and June 30, 2014, respectively.
Concentration of Credit Risk
	Concentration of Credit Risk
	The Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products.  The Company’s sales subject to credit risk are made primarily to department stores, perfumeries, specialty multi-brand retailers and retailers in its travel retail business.  The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk.
	The Company’s largest customer sells products primarily within the United States and accounted for $268.6 million, or 10%, and $284.0 million, or 11%, of the Company’s consolidated net sales for the three months ended March 31, 2015 and 2014, respectively, and $827.4 million, or 10%, and $907.0 million, or 11%, of the Company’s consolidated net sales for the nine months ended March 31, 2015 and 2014, respectively.  This customer accounted for $199.7 million, or 15%, and $158.5 million, or 11%, of the Company’s accounts receivable at March 31, 2015 and June 30, 2014, respectively.
Property, Plant and Equipment
	Property, Plant and Equipment
		March 31		June 30
	(In millions)	2015		2014
	Assets (Useful Life)
	Land	$	14.9	$	15.4
	Buildings and improvements (10 to 40 years)	195.5		205.0
	Machinery and equipment (3 to 10 years)	642.1		673.9
	Computer hardware and software (4 to 10 years)	985.0		994.8
	Furniture and fixtures (5 to 10 years)	68.0		75.1
	Leasehold improvements	1,534.5		1,565.7
		3,440.0		3,529.9
	Less accumulated depreciation and amortization	2,041.8		2,027.3
		$	1,398.2	$	1,502.6
	The cost of assets related to projects in progress of $156.8 million and $229.9 million as of March 31, 2015 and June 30, 2014, respectively, is included in their respective asset categories above.  Depreciation and amortization of property, plant and equipment was $97.2 million and $94.0 million during the three months ended March 31, 2015 and 2014, respectively, and $292.3 million and $275.1 million during the nine months ended March 31, 2015 and 2014, respectively.  Depreciation and amortization related to the Company’s manufacturing process is included in Cost of Sales, and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings.
Income Taxes
	Income Taxes
	The effective rate for income taxes was 29.2% and 35.1% for the three months ended March 31, 2015 and 2014, respectively.  The decrease in the effective income tax rate was primarily attributable to a reduction in the effective tax rate on the Company’s foreign operations, partially offset by an increase in income tax reserve adjustments. Contributing to a higher effective tax rate in the prior-year period was the impact of the Venezuelan remeasurement charge for which no tax benefit was provided.
	The effective rate for income taxes was 30.0% and 32.5% for the nine months ended March 31, 2015 and 2014, respectively.  The decrease in the effective income tax rate was primarily attributable to a reduction in the effective tax rate on the Company’s foreign operations, partially offset by an increase in income tax reserve adjustments.  Contributing to a higher effective tax rate in the prior-year period was the impact of the Venezuelan remeasurement charge for which no tax benefit was provided.
	As of March 31, 2015 and June 30, 2014, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $75.1 million and $58.1 million, respectively.  The total amount of unrecognized tax benefits at March 31, 2015 that, if recognized, would affect the effective tax rate was $51.6 million.  The total gross interest and penalties accrued related to unrecognized tax benefits during the three and nine months ended March 31, 2015 in the accompanying consolidated statements of earnings was $0.9 million and $5.7 million, respectively.  The total gross accrued interest and penalties in the accompanying consolidated balance sheets at March 31, 2015 and June 30, 2014 was $16.7 million and $12.5 million, respectively.  On the basis of the information available as of March 31, 2015, the Company does not expect any significant changes to the total amount of unrecognized tax benefits within the next 12 months.
	During the nine months ended March 31, 2015, the Company formally concluded the compliance process with respect to fiscal 2013 under the U.S. Internal Revenue Service Compliance Assurance Program.  The conclusion of this process did not impact the Company’s consolidated financial statements.
	As of March 31, 2015 and June 30, 2014, the Company had current net deferred tax assets of $262.3 million and $295.1 million, respectively, substantially all of which are included in Prepaid expenses and other current assets in the accompanying consolidated balance sheets.  In addition, the Company had noncurrent net deferred tax assets of $76.4 million and $85.5 million as of March 31, 2015 and June 30, 2014, respectively, substantially all of which are included in Other assets in the accompanying consolidated balance sheets.
Recently Adopted and Issued Accounting Standards
	Recently Adopted Accounting Standards
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance that requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carryforward, a similar tax loss, or a tax credit carryforward.  If either (i) an NOL carryforward, a similar tax loss, or tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position or (ii) the entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice), an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset.  This guidance became effective for unrecognized tax benefits that existed as of the Company’s fiscal 2015 first quarter.  The adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements.
	In March 2013, the FASB issued authoritative guidance to resolve the diversity in practice concerning the release of the cumulative translation adjustment (“CTA”) into net income (i) when a parent sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity, and (ii) in connection with a step acquisition of a foreign entity.  This amended guidance requires that CTA be released in net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, and that a pro rata portion of the CTA be released into net income upon a partial sale of an equity method investment in a foreign entity only.  In addition, the amended guidance clarifies the definition of a sale of an investment in a foreign entity to include both, events that result in the loss of a controlling financial interest in a foreign entity and events that result in an acquirer obtaining control of an acquiree in which it held an equity interest immediately prior to the date of acquisition.  The CTA should be released into net income upon the occurrence of such events.  This guidance became effective prospectively for the Company’s fiscal 2015 first quarter.  The adoption of this guidance did not have an impact on the Company’s consolidated financial statements.
	Recently Issued Accounting Standards
	In April 2015, the FASB issued authoritative guidance that simplifies the presentation of debt issuance costs.  Under the revised guidance, entities would no longer be able to recognize debt issuance costs as an asset in the balance sheet.  The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update.  This guidance becomes effective for the Company’s fiscal 2017 first quarter.  Early adoption is only permitted for financial statements that have not been previously issued.  Upon adoption, a reporting entity is required to apply the new guidance on a retrospective basis and required to comply with the applicable disclosures for a change in an accounting principle.  The Company will apply this new guidance retrospectively when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements.
	In April 2015, the FASB issued authoritative guidance to clarify the accounting treatment for fees paid by a customer in cloud computing arrangements.  Under the revised guidance, if a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses.  If the cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract.  The revised guidance will not change a customer’s accounting for service contracts. The guidance becomes effective for the Company’s fiscal 2017 first quarter, with early adoption permitted.  Upon adoption, a reporting entity can elect to apply the new guidance prospectively after the effective date, or retrospectively.  The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements.
	In June 2014, the FASB amended its authoritative guidance on accounting for certain share-based payment awards.  The amended guidance requires that if share-based compensation awards have terms of a performance target that affect vesting and that could be achieved after the requisite service period, such performance target should be treated as a performance condition.  As such, the performance target should not be reflected in estimating the grant-date fair value of the award and compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved.  This guidance becomes effective for the Company’s fiscal 2017 first quarter, with early adoption permitted.  The guidance will permit an entity to apply the amendments in the update either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the consolidated financial statements and to all new or modified awards thereafter.  The Company will apply this new guidance when it becomes effective, and is currently evaluating the impact of adoption on its consolidated financial statements.
	In May 2014, the FASB issued authoritative guidance that defines how companies should report revenues from contracts with customers.  The standard requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  It provides companies with a single comprehensive five-step principles-based model to use in accounting for revenue and supersedes current revenue recognition requirements, including most industry-specific and transaction-specific revenue guidance.  This guidance becomes effective for the Company’s fiscal 2018 first quarter, and early adoption is not permitted.  In April 2015, the FASB proposed a deferral of the effective date of the new revenue standard by one year.  The proposal will be subject to the FASB’s due process requirements, which include a period for public comments.  If the proposed deferral is passed, the new standard would not be effective for the Company until fiscal 2019.  The guidance permits an entity to apply the standard retrospectively to all prior periods presented, with certain practical expedients, or apply the requirements in the year of adoption, through a cumulative adjustment.  The Company will apply this new guidance when it becomes effective and has not yet selected a transition method.  The Company is currently evaluating the impact of adoption on its consolidated financial statements.
	In April 2014, the FASB issued authoritative guidance which changes the criteria for a disposal to qualify as a discontinued operation.  This revised standard defines a discontinued operation as (i) a component of an entity or group of components that has been disposed of or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (ii) an acquired business or nonprofit activity that is classified as held for sale on the date of acquisition.  The standard also requires expanded disclosures related to discontinued operations and added disclosure requirements for individually material disposal transactions that do not meet the discontinued operations criteria.  This guidance becomes effective prospectively for the Company’s fiscal 2016 first quarter, with early adoption permitted, but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available to be issued.  The Company will apply this new guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Mar. 31, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Inventory and Promotional Merchandise
		March 31		June 30
	(In millions)	2015		2014
	Raw materials	$	254.5	$	317.5
	Work in process	133.3		192.4
	Finished goods	551.2		599.5
	Promotional merchandise	134.1		184.6
		$	1,073.1	$	1,294.0
Property, Plant and Equipment
		March 31		June 30
	(In millions)	2015		2014
	Assets (Useful Life)
	Land	$	14.9	$	15.4
	Buildings and improvements (10 to 40 years)	195.5		205.0
	Machinery and equipment (3 to 10 years)	642.1		673.9
	Computer hardware and software (4 to 10 years)	985.0		994.8
	Furniture and fixtures (5 to 10 years)	68.0		75.1
	Leasehold improvements	1,534.5		1,565.7
		3,440.0		3,529.9
	Less accumulated depreciation and amortization	2,041.8		2,027.3
		$	1,398.2	$	1,502.6
Other Accrued Liabilities
		March 31		June 30
	(In millions)	2015		2014
	Advertising, merchandising and sampling	$	305.7	$	301.7
	Employee compensation	384.6		468.2
	Payroll and other taxes	155.0		161.2
	Accrued income taxes	147.9		113.6
	Other	471.2		469.1
		$	1,464.4	$	1,513.8

INVESTMENTS_Tables

INVESTMENTS (Tables)	9 Months Ended
	Mar. 31, 2015
INVESTMENTS
Schedule of gains and losses recorded in AOCI related to the Company's available-for-sale investments
	Gains and losses recorded in AOCI related to the Company’s available-for-sale investments as of March 31, 2015 were as follows:
	(In millions)	Cost			Gross			Gross			Fair Value
					Unrealized			Unrealized
					Gains			Losses
	U.S. government and agency securities	$	292.7		$	0.2		$	(0.1	)	$	292.8
	Foreign government and agency securities	20.5			—			—			20.5
	Corporate notes and bonds	166.7			0.2			(0.1		)	166.8
	Time deposits	12.9			—			—			12.9
	Other securities	30.2			1.2			—			31.4
	Total	$	523		$	1.6		$	(0.2	)	$	524.4
Schedule of available-for-sale securities by contractual maturity
	The following table presents the Company’s available-for-sale securities by contractual maturity as of March 31, 2015:
	(In millions)	Cost			Fair Value
	Due within one year	$	136.7		$	136.7
	Due after one through five years	386.3			387.7
		$	523.0		$	524.4
Schedule of unrealized losses that are not deemed to be other-than-temporarily impaired
	The following table presents the fair market value of the Company’s investments with gross unrealized losses that are not deemed to be other-than temporarily impaired as of March 31, 2015:
		In a Loss Position for Less Than 12						In a Loss Position for More Than 12
		Months						Months
	(In millions)	Fair Value			Gross Unrealized			Fair Value			Gross Unrealized
					Losses						Losses
	Available-for-sale securities	$	291.2		$	(0.2	)	$	—		$	—
Schedule of gross realized gains and losses on sales of investments
		Three Months Ended March 31						Nine Months Ended March 31
	(In millions)	2015			2014			2015			2014
	Gross realized gains	$	0.1		$	—		$	1.6		$	—
	Gross realized losses	(0.1		)	—			(0.1		)	—
	Total	$	—		$	—		$	1.5		$	—

GOODWILL_AND_OTHER_INTANGIBLE_1

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2015
GOODWILL AND OTHER INTANGIBLE ASSETS
Schedule of goodwill by product category and related change in the carrying amount
	(In millions)	Skin Care			Makeup			Fragrance			Hair Care			Total
	Balance as of June 30, 2014
	Goodwill	$	68.9		$	440.7		$	54.8		$	402.3		$	966.7
	Accumulated impairments	(33.6		)	—			—			(39.9		)	(73.5		)
		35.3			440.7			54.8			362.4			893.2
	Goodwill acquired during the period	121.2			7.2			133			—			261.4
	Translation adjustments	(0.6		)	(1.0		)	(2.0		)	(4.0		)	(7.6		)
		120.6			6.2			131			(4.0		)	253.8
	Balance as of March 31, 2015
	Goodwill	184.3			446.9			185.8			393.4			1,210.40
	Accumulated impairments	(28.4		)	—			—			(35.0		)	(63.4		)
		$	155.9		$	446.9		$	185.8		$	358.4		$	1,147.00
Other intangible assets, by type
		March 31, 2015									June 30, 2014
	(In millions)	Gross			Accumulated			Total Net			Gross			Accumulated			Total Net
		Carrying			Amortization			Book			Carrying			Amortization			Book
		Value						Value			Value						Value
	Amortizable intangible assets:
	Customer lists and other	$	293.7		$	225.0		$	68.7		$	268.3		$	216.7		$	51.6
	License agreements	43.0			43.0			—			43.0			43.0			—
		$	336.7		$	268.0		68.7			$	311.3		$	259.7		51.6
	Non-amortizable intangible assets:
	Trademarks and other							261.7									105.7
	Total intangible assets							$	330.4								$	157.3

DERIVATIVE_FINANCIAL_INSTRUMEN1

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Mar. 31, 2015
DERIVATIVE FINANCIAL INSTRUMENTS
Schedule of fair values of the derivative financial instruments included in the consolidated balance sheets
			Asset Derivatives								Liability Derivatives
					Fair Value (1)								Fair Value (1)
	(In millions)		Balance Sheet		March 31			June 30			Balance Sheet		March 31			June 30
			Location		2015			2014			Location		2015			2014
	Derivatives Designated as Hedging Instruments:
	Foreign currency forward contracts		Prepaid expenses and other current assets		$	67.4		$	3.4		Other accrued liabilities		$	2.1		$	18.2
	Derivatives Not Designated as Hedging Instruments:
	Foreign currency forward contracts		Prepaid expenses and other current assets		3.6			0.8			Other accrued liabilities		13.3			0.9
	Total Derivatives				$	71.0		$	4.2				$	15.4		$	19.1
		-1		See Note 6 — Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined.
Schedule of gains and losses related to derivative financial instruments designated as hedging instruments
			Amount of Gain or (Loss)						Location of Gain or		Amount of Gain or (Loss)
			Recognized in OCI on						(Loss) Reclassified		Reclassified from AOCI
			Derivatives						from AOCI into		into Earnings
			(Effective Portion)						Earnings		(Effective Portion) (1)
									(Effective Portion)
			Three Months Ended								Three Months Ended
			March 31								March 31
	(In millions)		2015			2014					2015			2014
	Derivatives in Cash-Flow Hedging Relationships:
	Foreign currency forward contracts		$	39.1		$	3.2		Cost of sales		$	3.6		$	1.1
									Selling, general and administrative		10.5			0.6
	Total derivatives		$	39.1		$	3.2				$	14.1		$	1.7
		-1		The amount of gain (loss) recognized in earnings related to the amount excluded from effectiveness testing was $(0.2) million and $0.3 million for the three months ended March 31, 2015 and 2014, respectively.  There was no gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships for the three months ended March 31, 2015 and 2014.
			Amount of Gain or (Loss)						Location of Gain or		Amount of Gain or (Loss)
			Recognized in OCI on						(Loss) Reclassified		Reclassified from AOCI
			Derivatives						from AOCI into		into Earnings
			(Effective Portion)						Earnings		(Effective Portion) (1)
									(Effective Portion)
			Nine Months Ended								Nine Months Ended
			March 31								March 31
	(In millions)		2015			2014					2015			2014
	Derivatives in Cash-Flow Hedging Relationships:
	Foreign currency forward contracts		$	103.2		$	(7.1	)	Cost of sales		$	5.4		$	3.6
									Selling, general and administrative		17.3			3.3
	Total derivatives		$	103.2		$	(7.1	)			$	22.7		$	6.9
		-1		The amount of gain (loss) recognized in earnings related to the amount excluded from effectiveness testing was $(1.0) million and $0.9 million for the nine months ended March 31, 2015 and 2014, respectively.  The amount of gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships was $0.6 million and $0.5 million for the nine months ended March 31, 2015 and 2014, respectively.
Schedule of gains and losses related to derivative financial instruments not designated as hedging instruments
					Amount of Gain or (Loss)
					Recognized in Earnings on Derivatives
			Location of Gain or (Loss)		Three Months Ended						Nine Months Ended
			Recognized in Earnings on		March 31						March 31
	(In millions)		Derivatives		2015			2014			2015			2014
	Foreign currency forward contracts		Selling, general and administrative		$	(9.8	)	$	(2.3	)	$	(9.7	)	$	(0.9	)

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2015
FAIR VALUE MEASUREMENTS
Financial assets and liabilities measured at fair value on a recurring basis
	The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2015:
	(In millions)	Level 1		Level 2		Level 3			Total
	Assets:
	Foreign currency forward contracts	$	—	$	71.0	$	—		$	71.0
	Available-for-sale securities:
	U.S. government and agency securities	—		292.8		—			292.8
	Foreign government and agency securities	—		20.5		—			20.5
	Corporate notes and bonds	—		166.8		—			166.8
	Time deposits	—		12.9		—			12.9
	Other securities	6.7		24.7		—			31.4
	Total	$	6.7	$	588.7	$	—		$	595.4
	Liabilities:
	Foreign currency forward contracts	$	—	$	15.4	$	—		$	15.4
	Contingent consideration	—		—		160.7			160.7
	Total	$	—	$	15.4	$	160.7		$	176.1
	The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2014:
	(In millions)	Level 1		Level 2		Level 3			Total
	Assets:
	Foreign currency forward contracts	$	—	$	4.2	$	—		$	4.2
	Available-for-sale securities	7.6		—		—			7.6
	Total	$	7.6	$	4.2	$	—		$	11.8
	Liabilities:
	Foreign currency forward contracts	$	—	$	19.1	$	—		$	19.1
Estimated fair values of financial instruments
		March 31				June 30
		2015				2014
	(In millions)	Carrying		Fair		Carrying			Fair
		Amount		Value		Amount			Value
	Nonderivatives
	Cash and cash equivalents	$	1,288.30	$	1,288.30	$	1,629.10		$	1,629.10
	Available-for-sale securities	524.4		524.4		7.6			7.6
	Note receivable	—		—		8.4			8.5
	Current and long-term debt	1,452.80		1,617.30		1,343.10			1,428.30
	Additional purchase price payable	36.9		36.9		—			—
	Contingent consideration	160.7		160.7		—			—
	Derivatives
	Foreign currency forward contracts, net — asset (liability)	55.6		55.6		(14.9		)	(14.9		)
Changes in the fair value of the contingent consideration obligations
	(In millions)	Fair Value
	Contingent consideration at June 30, 2014	$	—
	Acquisitions	156.6
	Change in fair value	4.1
	Contingent consideration at March 31, 2015	$	160.7

PENSION_AND_POSTRETIREMENT_BEN1

PENSION AND POST-RETIREMENT BENEFIT PLANS (Tables)	9 Months Ended
	Mar. 31, 2015
PENSION AND POST-RETIREMENT BENEFIT PLANS
Schedule of components of net periodic benefit cost for pension and other post-retirement benefit plans
	The components of net periodic benefit cost for the three months ended March 31, 2015 and 2014 consisted of the following:
														Other than
		Pension Plans												Pension Plans
		U.S.						International						Post-retirement
	(In millions)	2015			2014			2015			2014			2015			2014
	Service cost	$	8		$	7.9		$	5.7		$	6.2		$	0.8		$	0.8
	Interest cost	7.6			7.8			4.1			4.8			1.9			2
	Expected return on plan assets	(12.5		)	(11.7		)	(5.3		)	(5.2		)	(0.6		)	(0.5		)
	Amortization of:
	Prior service cost	0.1			0.1			0.5			0.7			0.2			0.3
	Actuarial loss	2.4			1.8			2.4			2.4			0.4			0.2
	Settlements and curtailments	—			—			(1.1		)	—			—			—
	Net periodic benefit cost	$	5.6		$	5.9		$	6.3		$	8.9		$	2.7		$	2.8
	The components of net periodic benefit cost for the nine months ended March 31, 2015 and 2014 consisted of the following:
														Other than
		Pension Plans												Pension Plans
		U.S.						International						Post-retirement
	(In millions)	2015			2014			2015			2014			2015			2014
	Service cost	$	23.8		$	23.7		$	18.2		$	18.5		$	2.5		$	2.5
	Interest cost	22.8			23.4			13.1			14.2			5.7			6
	Expected return on plan assets	(37.5		)	(35.1		)	(16.3		)	(15.4		)	(1.8		)	(1.5		)
	Amortization of:
	Prior service cost	0.4			0.5			1.6			2.1			0.6			0.7
	Actuarial loss	7.3			5.5			7.8			6.9			1.2			0.6
	Settlements and curtailments	—			—			(1.1		)	—			—			—
	Net periodic benefit cost	$	16.8		$	18		$	23.3		$	26.3		$	8.2		$	8.3
Schedule of amounts recognized in the consolidated balance sheets related to the entity's pension and post-retirement benefit plans
		March 31			June 30
	(In millions)	2015			2014
	Other assets	$	127.2		$	135.2
	Other accrued liabilities	(26.9		)	(26.9		)
	Other noncurrent liabilities	(358.8		)	(380.5		)
	Funded status	(258.5		)	(272.2		)
	Accumulated other comprehensive loss	294.2			338.2
	Net amount recognized	$	35.7		$	66

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Mar. 31, 2015
STOCK-BASED COMPENSATION
Schedule of stock-based compensation expense and related income tax benefits
			Three Months Ended						Nine Months Ended
			March 31						March 31
	(In millions)		2015			2014			2015			2014
	Compensation expense		$	33.0		$	29.9		$	133.9		$	124.8
	Income tax benefit		10.9			9.9			43.9			41.0
Summary of stock option programs and changes
	(Shares in thousands)		Shares		Weighted-			Aggregate			Weighted-
					Average			Intrinsic			Average
					Exercise			Value (1)			Contractual Life
					Price Per			(in millions)			Remaining in
					Share						Years
	Outstanding at June 30, 2014		14,127.80		$	41.51
	Granted at fair value		2,172.00		76.12
	Exercised		(2,219.8	)	37.62
	Expired		(21.6	)	36.97
	Forfeited		(89.4	)	65.02
	Outstanding at March 31, 2015		13,969.00		47.36			$	500.1		6.4
	Vested and expected to vest at March 31, 2015		13,845.40		47.15			$	498.6		6.4
	Exercisable at March 31, 2015		9,653.00		37.37			$	442		5.5
		-1		The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
Summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised
			Three Months Ended						Nine Months Ended
			March 31						March 31
	(In millions, except per share data)		2015			2014			2015			2014
	Per-share weighted-average grant date fair value of stock options granted		$	19.58		$	23.58		$	22.46		$	23.13
	Intrinsic value of stock options exercised		$	57.0		$	21.7		$	88.9		$	69.8
Schedule of fair value option-pricing assumptions
			Three Months Ended				Nine Months Ended
			March 31				March 31
			2015		2014		2015		2014
	Weighted-average expected stock-price volatility		27%		32%		28%		33%
	Weighted-average expected option life		7 years		7 years		7 years		7 years
	Average risk-free interest rate		1.60%		2.20%		2.20%		2.50%
	Average dividend yield		1.10%		1.10%		1.10%		1.10%
Summary of the status of Performance Share Units, (PSUs) and activity
					Weighted-Average
					Grant Date
	(Shares in thousands)		Shares		Fair Value Per Share
	Nonvested at June 30, 2014		538.6		$	63.53
	Granted		261.7		76.23
	Vested		—		—
	Forfeited		—		—
	Nonvested at March 31, 2015		800.3		67.68
Summary of the status of Restricted Stock Units (RSUs) and activity
					Weighted-Average
					Grant Date
	(Shares in thousands)		Shares		Fair Value Per Share
	Nonvested at June 30, 2014		2,222.10		$	62.21
	Granted		1,431.00		76.14
	Dividend equivalents		7.4		76.06
	Vested		(948.1	)	60.76
	Forfeited		(63.7	)	67.62
	Nonvested at March 31, 2015		2,648.70		70.17
Summary of the status of share units and activity under the Non-Employee Director Share Incentive Plan
					Weighted-Average
					Grant Date
	(Shares in thousands)		Shares		Fair Value Per Share
	Outstanding at June 30, 2014		98.8		$	37.67
	Granted		10.2		71.33
	Dividend equivalents		1.0		75.88
	Converted		—		—
	Outstanding at March 31, 2015		110.0		41.12

NET_EARNINGS_ATTRIBUTABLE_TO_T1

NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Tables)	9 Months Ended
	Mar. 31, 2015
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE
Schedule of reconciliation between the numerator and denominator of the basic and diluted EPS computations
		Three Months Ended				Nine Months Ended
		March 31				March 31
	(In millions, except per share data)	2015		2014		2015		2014
	Numerator:
	Net earnings attributable to The Estée Lauder Companies Inc.	$	272.1	$	213.2	$	935.9	$	946.4
	Denominator:
	Weighted-average common shares outstanding — Basic	378.5		385.8		380.1		387.3
	Effect of dilutive stock options	4.6		4.8		4.6		5.0
	Effect of RSUs	1.6		1.2		1.6		1.4
	Effect of PSUs based on TSR	—		—		—		0.1
	Effect of MSU	—		0.3		—		0.3
	Weighted-average common shares outstanding — Diluted	384.7		392.1		386.3		394.1
	Net earnings attributable to The Estée Lauder Companies Inc. per common share:
	Basic	$	0.72	$	0.55	$	2.46	$	2.44
	Diluted	0.71		0.54		2.42		2.40

EQUITY_Tables

EQUITY (Tables)	9 Months Ended
	Mar. 31, 2015
EQUITY
Schedule of equity
			Total Stockholders’ Equity — The Estée Lauder Companies Inc.																		Non-
	(In millions)		Common			Paid-in			Retained			AOCI			Treasury			Total			controlling			Total
			Stock			Capital			Earnings						Stock						Interests			Equity
	Balance at June 30, 2014		$	5.6		$	2,562.70		$	6,265.80		$	(100.3	)	$	(4,878.9	)	$	3,854.90		$	14.5		$	3,869.40
	Net earnings		—			—			935.9			—			—			935.9			3.7			939.6
	Common stock dividends		—			—			(259.6		)	—			—			(259.6		)	(5.8		)	(265.4		)
	Other comprehensive income (loss)		—			—			—			(308.6		)	—			(308.6		)	(2.6		)	(311.2		)
	Acquisition of treasury stock		—			—			—			—			(572.7		)	(572.7		)	—			(572.7		)
	Stock-based compensation		0.1			254			—			—			(48.9		)	205.2			—			205.2
	Balance at March 31, 2015		$	5.7		$	2,816.70		$	6,942.10		$	(408.9	)	$	(5,500.5	)	$	3,855.10		$	9.8		$	3,864.90
Summary of quarterly cash dividends declared per share on the Company's Class A and Class B Common Stock
	The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the nine months ended March 31, 2015:
	Date Declared		Record Date		Payable Date		Amount per Share
	August 14, 2014		August 29, 2014		September 15, 2014		$	0.2
	November 3, 2014		November 28, 2014		December 15, 2014		$	0.24
	February 4, 2015		February 27, 2015		March 16, 2015		$	0.24
Schedule of changes in AOCI, net of tax by component
	(In millions)		Net			Net			Amounts			Translation			Total
			Unrealized			Derivative			Included in			Adjustments
			Investment			Instrument			Net Periodic
			Gain (Loss)			Gain (Loss)			Benefit Cost
	Balance at June 30, 2014		$	1.4		$	(0.9	)	$	(233.0	)	$	132.2		$	(100.3	)
	OCI before reclassifications		0.6			66.6			20		-1	(392.5		)	(305.3		)
	Amounts reclassified from AOCI		(1.0		)	(14.8		)	12.5			—			(3.3		)
	Net current-period OCI		(0.4		)	51.8			32.5			(392.5		)	(308.6		)
	Balance at March 31, 2015		$	1		$	50.9		$	(200.5	)	$	(260.3	)	$	(408.9	)
		-1		Includes foreign currency translation gains of $21.0 million.
Schedule of effects of reclassification adjustments from AOCI into net earnings
			Amount Reclassified from AOCI
			Three Months Ended						Nine Months Ended						Affected Line Item in
			March 31						March 31						Consolidated
	(In millions)		2015			2014			2015			2014			Statement of Earnings
	Gain (Loss) on Available-For-Sale Securities
	Available-for-sale securities		$	—		$	—		$	1.5		$	—		Interest income and investment income, net
	Benefit (provision) for deferred taxes		(0.1		)	—			(0.5		)	—			Provision for income taxes
			$	(0.1	)	$	—		$	1		$	—		Net earnings
	Gain (Loss) on Cash-Flow Hedges
	Foreign currency forward contracts		$	3.6		$	1.1		$	5.4		$	3.6		Cost of sales
	Foreign currency forward contracts		10.5			0.6			17.3			3.3			Selling, general and administrative
			14.1			1.7			22.7			6.9			Earnings before income taxes
	Benefit (provision) for deferred taxes		(4.9		)	(0.5		)	(8.0		)	(2.3		)	Provision for income taxes
			$	9.2		$	1.2		$	14.7		$	4.6		Net earnings
	Gain (Loss) on Fair-Value Hedges
	Settled interest rate-related derivatives		$	—		$	0.1		$	0.2		$	0.2		Interest expense
	Benefit (provision) for deferred taxes		—			—			(0.1		)	(0.1		)	Provision for income taxes
			$	—		$	0.1		$	0.1		$	0.1		Net earnings
	Amounts Included in Net Periodic Benefit Cost
	Amortization of prior service cost		$	(0.8	)	$	(1.1	)	$	(2.6	)	$	(3.3	)(1)
	Amortization of actuarial loss		(5.2		)	(4.4		)	(16.3		)	(13.0		)(1)
	Settlements and curtailments		1.1			—			1.1			—		-1
			(4.9		)	(5.5		)	(17.8		)	(16.3		)	Earnings before income taxes
	Benefit (provision) for deferred taxes		1.5			1.6			5.3			4.7			Provision for income taxes
			$	(3.4	)	$	(3.9	)	$	(12.5	)	$	(11.6	)	Net earnings
	Total reclassification adjustments, net		$	5.7		$	(2.6	)	$	3.3		$	(6.9	)	Net earnings
		-1		See Note 7 — Pension and Post-Retirement Benefit Plans for additional information.

STATEMENT_OF_CASH_FLOWS_Tables

STATEMENT OF CASH FLOWS (Tables)	9 Months Ended
	Mar. 31, 2015
STATEMENT OF CASH FLOWS
Supplemental cash flow information
	(In millions)	2015			2014
	Cash:
	Cash paid during the period for interest	$	41.3		$	41.1
	Cash paid during the period for income taxes	$	317.6		$	357.6
	Non-cash investing and financing activities:
	Incremental tax benefit from the exercise of stock options	$	(8.6	)	$	(5.1	)
	Capital lease obligations incurred	$	7.6		$	12
	Accrued dividend distribution to noncontrolling interest	$	1.4		$	2.4

SEGMENT_DATA_AND_RELATED_INFOR1

SEGMENT DATA AND RELATED INFORMATION (Tables)	9 Months Ended
	Mar. 31, 2015
SEGMENT DATA AND RELATED INFORMATION
Schedule of segment data and related information
		Three Months Ended						Nine Months Ended
		March 31						March 31
	(In millions)	2015			2014			2015			2014
	PRODUCT CATEGORY DATA
	Net Sales:
	Skin Care	$	1,101.00		$	1,132.10		$	3,466.80		$	3,564.40
	Makeup	1,082.50			1,015.70			3,280.00			3,145.80
	Fragrance	263.2			270.5			1,080.30			1,115.70
	Hair Care	125.6			120.8			390.8			380.7
	Other	8.2			10.7			38.1			36.8
		2,580.50			2,549.80			8,256.00			8,243.40
	Adjustments associated with restructuring activities	—			—			—			0.1
	Net Sales	$	2,580.50		$	2,549.80		$	8,256.00		$	8,243.50
	Operating Income (Loss) before total adjustments associated with restructuring activities:
	Skin Care	$	215.7		$	179		$	709.2		$	758.6
	Makeup	159.3			149.9			538.6			564.5
	Fragrance	17.5			(1.9		)	104			95.5
	Hair Care	7.1			13.2			32.1			29.3
	Other	(2.4		)	1.6			(5.9		)	(2.6		)
		397.2			341.8			1,378.00			1,445.30
	Reconciliation:
	Total adjustments associated with restructuring activities	—			(0.2		)	—			2.1
	Interest expense	(15.2		)	(15.0		)	(45.0		)	(44.2		)
	Interest income and investment income, net	3.1			2.7			8.5			6
	Earnings before income taxes	$	385.1		$	329.3		$	1,341.50		$	1,409.20
	GEOGRAPHIC DATA
	Net Sales:
	The Americas	$	1,109.90		$	1,072.00		$	3,426.10		$	3,469.00
	Europe, the Middle East & Africa	950.3			959.4			3,104.00			3,031.60
	Asia/Pacific	520.3			518.4			1,725.90			1,742.80
		2,580.50			2,549.80			8,256.00			8,243.40
	Adjustments associated with restructuring activities	—			—			—			0.1
	Net Sales	$	2,580.50		$	2,549.80		$	8,256.00		$	8,243.50
	Operating Income (Loss):
	The Americas	$	109.6		$	111.5		$	287.8		$	419.7
	Europe, the Middle East & Africa	204.3			160.2			729.4			673.4
	Asia/Pacific	83.3			70.1			360.8			352.2
		397.2			341.8			1,378.00			1,445.30
	Total adjustments associated with restructuring activities	—			(0.2		)	—			2.1
	Operating Income	$	397.2		$	341.6		$	1,378.00		$	1,447.40

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Currency Translation and Transactions
Unrealized translation gains (losses), net of tax	($144.40)	($7.60)	($392.50)	$50.40
Loss on Venezuela remeasurement	5.3	38.3	5.3	38.3
Net exchange gains (losses) on foreign currency transactions	7.2	-41.7	-9.2	-48.1
Accounts Receivable
Allowance for doubtful accounts and customer deductions	20.7		20.7		23.9
Concentration of Credit Risk
Net Sales	2,580.50	2,549.80	8,256	8,243.50
Accounts receivable, net	1,350.20		1,350.20		1,379.30
Inventory and Promotional Merchandise
Raw materials	254.5		254.5		317.5
Work in process	133.3		133.3		192.4
Finished goods	551.2		551.2		599.5
Promotional merchandise	134.1		134.1		184.6
Inventory and promotional merchandise, net	1,073.10		1,073.10		1,294
Net Sales | Largest Customer
Concentration of Credit Risk
Net Sales	268.6	284	827.4	907
Concentration of credit risk (as a percent)	10.00%	11.00%	10.00%	11.00%
Accounts Receivable | Largest Customer
Concentration of Credit Risk
Accounts receivable, net	$199.70		$199.70		$158.50
Concentration of credit risk (as a percent)			15.00%		11.00%
Venezuelan bolivar fuerte
Currency Translation and Transactions
Exchange rate used to remeasure the monetary assets and liabilities of the Venezuelan subsidiary						6.3
Venezuelan bolivar fuerte | SICAD II
Currency Translation and Transactions
Exchange rate used to remeasure the monetary assets and liabilities of the Venezuelan subsidiary		49.81		49.81
Venezuelan bolivar fuerte | SIMADI
Currency Translation and Transactions
Exchange rate used to remeasure the monetary assets and liabilities of the Venezuelan subsidiary	191.97		191.97

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Property, Plant and Equipment
Property, Plant and Equipment	$3,440		$3,440		$3,529.90
Less accumulated depreciation and amortization	2,041.80		2,041.80		2,027.30
Property, Plant and Equipment, net	1,398.20		1,398.20		1,502.60
Cost of assets related to projects in progress	156.8		156.8		229.9
Depreciation and amortization of property, plant and equipment	97.2	94	292.3	275.1
Land
Property, Plant and Equipment
Property, Plant and Equipment	14.9		14.9		15.4
Buildings and improvements
Property, Plant and Equipment
Property, Plant and Equipment	195.5		195.5		205
Buildings and improvements | Minimum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			10 years
Buildings and improvements | Maximum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			40 years
Machinery and equipment
Property, Plant and Equipment
Property, Plant and Equipment	642.1		642.1		673.9
Machinery and equipment | Minimum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			3 years
Machinery and equipment | Maximum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			10 years
Computer hardware and software
Property, Plant and Equipment
Property, Plant and Equipment	985		985		994.8
Computer hardware and software | Minimum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			4 years
Computer hardware and software | Maximum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			10 years
Furniture and fixtures
Property, Plant and Equipment
Property, Plant and Equipment	68		68		75.1
Furniture and fixtures | Minimum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			5 years
Furniture and fixtures | Maximum
Property, Plant and Equipment
Property, Plant and Equipment, Useful Life			10 years
Leasehold improvements
Property, Plant and Equipment
Property, Plant and Equipment	$1,534.50		$1,534.50		$1,565.70

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Other Accrued Liabilities
Advertising, merchandising and sampling	$305.70		$305.70		$301.70
Employee compensation	384.6		384.6		468.2
Payroll and other taxes	155		155		161.2
Accrued income taxes	147.9		147.9		113.6
Other	471.2		471.2		469.1
Total	1,464.40		1,464.40		1,513.80
Income Taxes
Effective tax rate (as a percent)	29.20%	35.10%	30.00%	32.50%
Tax benefit on impact of Venezuelan remeasurement		0		0
Gross unrecognized tax benefits	75.1		75.1		58.1
Total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate	51.6		51.6
Total gross interest and penalties related to unrecognized tax benefits	0.9		5.7
Gross accrued interest and penalties related to unrecognized tax benefits	16.7		16.7		12.5
Current net deferred tax assets	262.3		262.3		295.1
Noncurrent net deferred tax assets	$76.40		$76.40		$85.50

INVESTMENTS_Details

INVESTMENTS (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
In Millions, unless otherwise specified
Gains and losses recorded in AOCI
Cost	$523
Gross Unrealized Gains	1.6
Gross Unrealized Losses	-0.2
Fair Value	524.4
Gross unrealized investment gains recorded in AOCI		2.1
U.S. government and agency securities
Gains and losses recorded in AOCI
Cost	292.7
Gross Unrealized Gains	0.2
Gross Unrealized Losses	-0.1
Fair Value	292.8
Foreign government and agency securities
Gains and losses recorded in AOCI
Cost	20.5
Fair Value	20.5
Corporate notes and bonds
Gains and losses recorded in AOCI
Cost	166.7
Gross Unrealized Gains	0.2
Gross Unrealized Losses	-0.1
Fair Value	166.8
Time deposits
Gains and losses recorded in AOCI
Cost	12.9
Fair Value	12.9
Other securities
Gains and losses recorded in AOCI
Cost	30.2
Gross Unrealized Gains	1.2
Fair Value	$31.40

INVESTMENTS_Details_2

INVESTMENTS (Details 2) (USD $)	Mar. 31, 2015
In Millions, unless otherwise specified
Available-for-sale securities by contractual maturity
Due within one year, Cost	$136.70
Due after one through five years, Cost	386.3
Cost, Total	523
Due within one year, Fair Value	136.7
Due after one through five years, Fair Value	387.7
Fair Value, Total	$524.40

INVESTMENTS_Details_3

INVESTMENTS (Details 3) (Available-for-sale securities, USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Available-for-sale securities
Fair market value of investments with unrealized losses not deemed to be other-than temporarily impaired
In a Loss Position for Less Than 12 Months, Fair Value	$291.20
In a Loss Position for Less Than 12 Months, Gross Unrealized Losses	($0.20)

INVESTMENTS_Details_4

INVESTMENTS (Details 4) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2015
Gross gains and losses realized on sales of investments
Gross realized gains	$0.10	$1.60
Gross realized losses	-0.1	-0.1
Gross realized gains (losses) on sales of investments		$1.50

ACQUISITION_OF_BUSINESSES_Deta

ACQUISITION OF BUSINESSES (Details) (Le Labo, RODIN olio lusso, Editions de Parfums Frederic Malle and GLAMGLOW, USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Le Labo, RODIN olio lusso, Editions de Parfums Frederic Malle and GLAMGLOW
Acquisition of Businesses
Aggregate acquisition-date fair value	$445

GOODWILL_AND_OTHER_INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014
Goodwill by reporting unit
Goodwill, gross	$1,210.40	$966.70
Accumulated impairments	-63.4	-73.5
Changes in goodwill
Goodwill at the beginning of the period	893.2
Goodwill acquired during the period	261.4
Translation adjustments	-7.6
Goodwill, Period Increase (Decrease)	253.8
Goodwill at the end of the period	1,147
Le Labo, RODIN olio lusso, Editions de Parfums Frederic Malle and GLAMGLOW
Business acquisitions
Amortizable intangible assets	27.5
Weighted-average amortization period	9 years
Non-amortizable assets	157.2
Changes in goodwill
Goodwill acquired during the period	254.2
Goodwill expected to be deductible for tax purposes	159
Bobbi Brown brand
Changes in goodwill
Goodwill acquired during the period	7.2
Skin Care
Goodwill by reporting unit
Goodwill, gross	184.3	68.9
Accumulated impairments	-28.4	-33.6
Changes in goodwill
Goodwill at the beginning of the period	35.3
Goodwill acquired during the period	121.2
Translation adjustments	-0.6
Goodwill, Period Increase (Decrease)	120.6
Goodwill at the end of the period	155.9
Makeup
Goodwill by reporting unit
Goodwill, gross	446.9	440.7
Changes in goodwill
Goodwill at the beginning of the period	440.7
Goodwill acquired during the period	7.2
Translation adjustments	-1
Goodwill, Period Increase (Decrease)	6.2
Goodwill at the end of the period	446.9
Fragrance
Goodwill by reporting unit
Goodwill, gross	185.8	54.8
Changes in goodwill
Goodwill at the beginning of the period	54.8
Goodwill acquired during the period	133
Translation adjustments	-2
Goodwill, Period Increase (Decrease)	131
Goodwill at the end of the period	185.8
Hair Care
Goodwill by reporting unit
Goodwill, gross	393.4	402.3
Accumulated impairments	-35	-39.9
Changes in goodwill
Goodwill at the beginning of the period	362.4
Translation adjustments	-4
Goodwill, Period Increase (Decrease)	-4
Goodwill at the end of the period	$358.40

GOODWILL_AND_OTHER_INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Amortizable intangible assets:
Gross Carrying Value	$336.70		$336.70		$311.30
Accumulated Amortization	268		268		259.7
Total Net Book Value	68.7		68.7		51.6
Aggregate amortization expense for amortizable intangible assets	3.6	3	9.7	9.3
Non-amortizable intangible assets:
Trademarks and other	261.7		261.7		105.7
Total intangible assets	330.4		330.4		157.3
Estimated aggregate amortization expense
Estimated aggregate amortization expense for remainder of fiscal year 2015	3.9		3.9
Estimated aggregate amortization expense for fiscal year 2016	15.2		15.2
Estimated aggregate amortization expense for fiscal year 2017	13.2		13.2
Estimated aggregate amortization expense for fiscal year 2018	11.7		11.7
Estimated aggregate amortization expense for fiscal year 2019	10.7		10.7
Customer lists and other
Amortizable intangible assets:
Gross Carrying Value	293.7		293.7		268.3
Accumulated Amortization	225		225		216.7
Total Net Book Value	68.7		68.7		51.6
License agreements
Amortizable intangible assets:
Gross Carrying Value	43		43		43
Accumulated Amortization	$43		$43		$43

DERIVATIVE_FINANCIAL_INSTRUMEN2

DERIVATIVE FINANCIAL INSTRUMENTS (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
In Millions, unless otherwise specified
Derivatives, Fair Value
Total Derivative asset, fair value	$71	$4.20
Total Derivative liability, fair value	15.4	19.1
Derivatives designated as hedging instruments | Foreign currency forward contracts | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	67.4	3.4
Derivatives designated as hedging instruments | Foreign currency forward contracts | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	2.1	18.2
Derivatives not designated as hedging instruments | Foreign currency forward contracts | Prepaid expenses and other current assets
Derivatives, Fair Value
Derivative asset, fair value	3.6	0.8
Derivatives not designated as hedging instruments | Foreign currency forward contracts | Other accrued liabilities
Derivatives, Fair Value
Derivative liability, fair value	$13.30	$0.90

DERIVATIVE_FINANCIAL_INSTRUMEN3

DERIVATIVE FINANCIAL INSTRUMENTS (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Foreign currency forward contracts | Selling, general and administrative | Derivatives not designated as hedging instruments
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in Earnings on Derivatives	($9.80)	($2.30)	($9.70)	($0.90)
Derivatives in cash flow hedging relationships
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	39.1	3.2	103.2	-7.1
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion)	14.1	1.7	22.7	6.9
Net gain (loss) recognized in earnings related to the amount excluded from effectiveness testing	-0.2	0.3	-1	0.9
Net gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships	0	0	0.6	0.5
Derivatives in cash flow hedging relationships | Foreign currency forward contracts
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	39.1	3.2	103.2	-7.1
Derivatives in cash flow hedging relationships | Foreign currency forward contracts | Cost of sales
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion)	3.6	1.1	5.4	3.6
Derivatives in cash flow hedging relationships | Foreign currency forward contracts | Selling, general and administrative
Gain (loss) on derivative financial instruments
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion)	$10.50	$0.60	$17.30	$3.30

DERIVATIVE_FINANCIAL_INSTRUMEN4

DERIVATIVE FINANCIAL INSTRUMENTS (Details 3) (USD $)	Mar. 31, 2015	Jun. 30, 2014
In Millions, unless otherwise specified
Credit Risk
Minimum number of nationally recognized rating agencies	2
Credit-risk-related contingent features
Derivative contracts, number of counterparties	2
Credit-risk-related derivative contracts in net asset position, fair value	$19.20
Derivative
Credit Risk
Maximum exposure to credit risk in the event of nonperformance by counterparties, gross fair value of contracts in asset positions	71
Foreign currency forward contracts
Foreign Currency Cash-Flow Hedges
Amount expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months	32.6
Foreign currency forward contracts | Net Derivative Instrument Gain (Loss)
Foreign Currency Cash-Flow Hedges
Accumulated gain (loss) on derivative instruments in AOCI, before tax	68	-12.5
Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	2,162.10
British pound | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	442.1
Euro | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	333.4
Swiss franc | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	307.7
Canadian dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	162.2
Hong Kong dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	148.8
Australian dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	140.8
Japanese yen | Foreign currency forward contracts | Derivatives in cash flow hedging relationships
Foreign Currency Cash-Flow Hedges
Notional amount of foreign currency forward contracts	$101.10

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
In Millions, unless otherwise specified
Assets:
Foreign currency forward contracts	$71	$4.20
Available-for-sale securities	524.4
Liabilities:
Foreign currency forward contracts	15.4	19.1
Contingent consideration	160.7
Fair Value
Assets:
Available-for-sale securities	524.4	7.6
Liabilities:
Contingent consideration	160.7
U.S. government and agency securities
Assets:
Available-for-sale securities	292.8
Foreign government and agency securities
Assets:
Available-for-sale securities	20.5
Corporate notes and bonds
Assets:
Available-for-sale securities	166.8
Time deposits
Assets:
Available-for-sale securities	12.9
Recurring basis | Fair Value
Assets:
Foreign currency forward contracts	71	4.2
Available-for-sale securities		7.6
Total	595.4	11.8
Liabilities:
Foreign currency forward contracts	15.4	19.1
Contingent consideration	160.7
Total	176.1
Recurring basis | Level 1
Assets:
Available-for-sale securities		7.6
Total	6.7	7.6
Recurring basis | Level 2
Assets:
Foreign currency forward contracts	71	4.2
Total	588.7	4.2
Liabilities:
Foreign currency forward contracts	15.4	19.1
Total	15.4
Recurring basis | Level 3
Liabilities:
Contingent consideration	160.7
Total	160.7
Recurring basis | U.S. government and agency securities | Fair Value
Assets:
Available-for-sale securities	292.8
Recurring basis | U.S. government and agency securities | Level 2
Assets:
Available-for-sale securities	292.8
Recurring basis | Foreign government and agency securities | Fair Value
Assets:
Available-for-sale securities	20.5
Recurring basis | Foreign government and agency securities | Level 2
Assets:
Available-for-sale securities	20.5
Recurring basis | Corporate notes and bonds | Fair Value
Assets:
Available-for-sale securities	166.8
Recurring basis | Corporate notes and bonds | Level 2
Assets:
Available-for-sale securities	166.8
Recurring basis | Time deposits | Fair Value
Assets:
Time deposits	12.9
Recurring basis | Time deposits | Level 2
Assets:
Time deposits	12.9
Recurring basis | Other securities | Fair Value
Assets:
Available-for-sale securities	31.4
Recurring basis | Other securities | Level 1
Assets:
Available-for-sale securities	6.7
Recurring basis | Other securities | Level 2
Assets:
Available-for-sale securities	$24.70

FAIR_VALUE_MEASUREMENTS_Detail1

FAIR VALUE MEASUREMENTS (Details 2) (USD $)	0 Months Ended	1 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Aug. 31, 2014	Mar. 31, 2015
Nonderivatives
Available-for-sale securities			$524.40
Contingent consideration			160.7
Implied market rate applied to fair value of the receivable related to sale of assets (as a percent)	6.10%
Remaining principal amount received on note receivable		8.4
Changes in the fair value of the contingent consideration obligations
Acquisitions			156.6
Change in fair value			4.1
Contingent consideration at March 31, 2015			160.7
Additional Purchase Price Payable | Level 2
Nonderivatives
Discount rate (as a percent)			1.00%
Contingent Consideration | Level 3
Nonderivatives
Basis points (as a percent)			1.00%
Contingent consideration value change due to increase or decrease in risk premium basis points			6
Contingent Consideration | Minimum | Level 3
Nonderivatives
Discount rate (as a percent)			9.00%
Contingent Consideration | Maximum | Level 3
Nonderivatives
Discount rate (as a percent)			14.00%
LIBOR | Foreign currency forward contracts
Foreign currency forward contracts
Contract maturities, maximum			12 months
Swap yield curve | Foreign currency forward contracts
Foreign currency forward contracts
Contract maturities greater than			12 months
Carrying Value
Nonderivatives
Cash and cash equivalents	1,629.10		1,288.30
Available-for-sale securities	7.6		524.4
Note receivable	8.4
Current and long-term debt	1,343.10		1,452.80
Additional purchase price payable			36.9
Contingent consideration			160.7
Changes in the fair value of the contingent consideration obligations
Contingent consideration at March 31, 2015			160.7
Carrying Value | Foreign currency forward contracts
Derivatives
Foreign currency forward contracts - net asset (liability)	-14.9		55.6
Fair Value
Nonderivatives
Cash and cash equivalents	1,629.10		1,288.30
Available-for-sale securities	7.6		524.4
Note receivable	8.5
Current and long-term debt	1,428.30		1,617.30
Additional purchase price payable			36.9
Contingent consideration			160.7
Changes in the fair value of the contingent consideration obligations
Contingent consideration at March 31, 2015			160.7
Fair Value | Foreign currency forward contracts
Derivatives
Foreign currency forward contracts - net asset (liability)	-14.9		$55.60

PENSION_AND_POSTRETIREMENT_BEN2

PENSION AND POST-RETIREMENT BENEFIT PLANS (Details) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Apr. 30, 2015	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Amounts recognized in the consolidated balance sheets related to the entity's pension and post-retirement benefit plans consist of:
Other assets		$127.20		$127.20		$135.20
Other accrued liabilities		-26.9		-26.9		-26.9
Other noncurrent liabilities		-358.8		-358.8		-380.5
Funded status		-258.5		-258.5		-272.2
Accumulated other comprehensive loss		294.2		294.2		338.2
Net amount recognized		35.7		35.7		66
Pension Plans U.S.
Components of net periodic benefit cost:
Service cost		8	7.9	23.8	23.7
Interest cost		7.6	7.8	22.8	23.4
Expected return on plan assets		-12.5	-11.7	-37.5	-35.1
Amortization of:
Prior service cost		0.1	0.1	0.4	0.5
Actuarial loss		2.4	1.8	7.3	5.5
Net periodic benefit cost		5.6	5.9	16.8	18
Employer contributions	25
Pension Plans International
Components of net periodic benefit cost:
Service cost		5.7	6.2	18.2	18.5
Interest cost		4.1	4.8	13.1	14.2
Expected return on plan assets		-5.3	-5.2	-16.3	-15.4
Amortization of:
Prior service cost		0.5	0.7	1.6	2.1
Actuarial loss		2.4	2.4	7.8	6.9
Settlements and curtailments		-1.1		-1.1
Net periodic benefit cost		6.3	8.9	23.3	26.3
Employer contributions				10
Post-retirement benefit other than pension plans
Components of net periodic benefit cost:
Service cost		0.8	0.8	2.5	2.5
Interest cost		1.9	2	5.7	6
Expected return on plan assets		-0.6	-0.5	-1.8	-1.5
Amortization of:
Prior service cost		0.2	0.3	0.6	0.7
Actuarial loss		0.4	0.2	1.2	0.6
Net periodic benefit cost		$2.70	$2.80	$8.20	$8.30

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award
Compensation expense	$33	$29.90	$133.90	$124.80
Income tax benefit	10.9	9.9	43.9	41
Total unrecognized compensation cost related to unvested stock-based awards	138.9		138.9
Weighted-average period over which compensation cost related to unvested stock-based awards is expected to be recognized			2 years
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of Class A Common Stock shares reserved and available to be granted pursuant to equity compensation plans	11,067,200		11,067,200
Stock options
Shares
Outstanding at the beginning of the year (in shares)			14,127,800
Granted at fair value (in shares)			2,172,000
Exercised (in shares)			-2,219,800
Expired (in shares)			-21,600
Forfeited (in shares)			-89,400
Outstanding at the end of the period (in shares)	13,969,000		13,969,000
Vested and expected to vest (in shares)	13,845,400		13,845,400
Exercisable (in shares)	9,653,000		9,653,000
Weighted-Average Exercise Price Per Share
Outstanding at the beginning of the year (in dollars per share)			$41.51
Granted at fair value (in dollars per share)			$76.12
Exercised (in dollars per share)			$37.62
Expired (in dollars per share)			$36.97
Forfeited (in dollars per share)			$65.02
Outstanding at the end of the period (in dollars per share)	$47.36		$47.36
Vested and expected to vest Weighted-Average Exercise Price (in dollars per share)	$47.15		$47.15
Exercisable Weighted-Average Exercise Price (in dollars per share)	$37.37		$37.37
Additional General Disclosures
Outstanding Aggregate Intrinsic Value (in dollars)	500.1		500.1
Weighted-Average Contractual Life Remaining			6 years 4 months 24 days
Vested and expected to vest Aggregate Intrinsic Value (in dollars)	498.6		498.6
Vested and expected to vest Exercisable Weighted-Average Contractual Life Remaining			6 years 4 months 24 days
Exercisable Aggregate Intrinsic Value (in dollars)	442		442
Exercisable Weighted-Average Contractual Life Remaining			5 years 6 months
Per-share weighted-average grant date fair value of stock options granted (in dollars per share)	$19.58	$23.58	$22.46	$23.13
Intrinsic value of stock options exercised (in dollars)	$57	$21.70	$88.90	$69.80
Fair Value Of Option Grants, Assumptions and Methodology
Method used for estimating fair value of option grant			Black-Scholes
Weighted-average expected stock-price volatility (as a percent)	27.00%	32.00%	28.00%	33.00%
Weighted-average expected option life	7 years	7 years	7 years	7 years
Average risk-free interest rate (as a percent)	1.60%	2.20%	2.20%	2.50%
Average dividend yield (as a percent)	1.10%	1.10%	1.10%	1.10%

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Details 2) (USD $)	9 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended	3 Months Ended		9 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Jun. 30, 2014	Sep. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2014
Performance Share Units
Other Equity Compensation Plans
Nonvested at the beginning of the period (in shares)	538,600
Granted (in shares)	261,700
Vested (in shares)		-259,700
Nonvested at the end of the period (in shares)	800,300	538,600			538,600	800,300
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$63.53
Granted (in dollars per share)	$76.23
Nonvested at the end of the period (in dollars per share)	$67.68	$63.53			$63.53	$67.68
Performance Share Units | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Common Stock issued (in shares)			377,300
RSUs
Other Equity Compensation Plans
Nonvested at the beginning of the period (in shares)	2,222,100
Granted (in shares)	1,431,000
Dividend equivalents (in shares)	7,400
Vested (in shares)	-948,100
Forfeited (in shares)	-63,700
Nonvested at the end of the period (in shares)	2,648,700					2,648,700
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)	$62.21
Granted (in dollars per share)	$76.14
Dividend equivalents (in dollars per share)	$76.06
Vested (in dollars per share)	$60.76
Forfeited (in dollars per share)	$67.62
Nonvested at the end of the period (in dollars per share)	$70.17					$70.17
Non-Employee Director Plans
Dividend equivalents (in shares)	7,400
Weighted-Average Grant Date Fair Value Per Share
Dividend equivalents (in dollars per share)	$76.06
RSUs | RSU grants scheduled to vest in fiscal 2016
Other Equity Compensation Plans
RSU grants scheduled to vest (in shares)	501,700
RSUs | RSU grants scheduled to vest in fiscal 2017
Other Equity Compensation Plans
RSU grants scheduled to vest (in shares)	517,600
RSUs | RSU grants scheduled to vest in fiscal 2018
Other Equity Compensation Plans
RSU grants scheduled to vest (in shares)	411,700
Performance share units based on total stockholder return
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Grant date fair value (in USD)	$11					$11
Method used for estimating grant date fair value	lattice model with a Monte Carlo
Dividend yield (as a percent)	1.00%
Weighted-average expected volatility (as a percent)	32.00%
Performance share units based on total stockholder return | Performance share units based on total stockholders return vesting (contractual term 33 months)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Weighted-average expected option life	33 months
Weighted-average risk-free interest rate (as a percent)	0.30%
Performance share units based on total stockholder return | Performance share units based on total stockholders return vesting (contractual term 45 months)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Weighted-average expected option life	45 months
Weighted-average risk-free interest rate (as a percent)	0.50%
Performance share units based on total stockholder return | Performance share units based on total stockholders return vesting (contractual term 57 months)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Weighted-average expected option life	57 months
Weighted-average risk-free interest rate (as a percent)	0.70%
Performance share units based on total stockholder return | Common Class A | Executive
Share-based Compensation Arrangement by Share-based Payment Award
Target payout for performance share units in Class A Common Stock (in shares)				162,760
Performance share units based on total stockholder return | Common Class A | Maximum | Executive
Share-based Compensation Arrangement by Share-based Payment Award
Target payout for performance share units in Class A Common Stock (in shares)	260,416
MSU
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Grant date fair value (in USD)	10.6					10.6
Number of shares outstanding		1			1
Method used for estimating grant date fair value	lattice model with a Monte Carlo
Contractual life	41 months
Weighted-average risk-free interest rate (as a percent)	1.60%
Dividend yield (as a percent)	1.00%
Weighted-average expected volatility (as a percent)	29.00%
MSU | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Average closing stock price per share					$75
MSU | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of trading days on exchange for average closing stock price per share					20 days
MSU | Common Class A | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Target payout for performance share units in Class A Common Stock (in shares)	320,000
Share Units
Other Equity Compensation Plans
Dividend equivalents (in shares)	1,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value
Dividend equivalents (in dollars per share)	$75.88
Non-Employee Director Plans
Outstanding at the beginning of the period (in shares)	98,800
Granted (in shares)	10,200
Dividend equivalents (in shares)	1,000
Outstanding at the end of the period (in shares)	110,000					110,000
Weighted-Average Grant Date Fair Value Per Share
Outstanding at the beginning of the period (in dollars per share)	$37.67
Granted (in dollars per share)	$71.33
Dividend equivalents (in dollars per share)	$75.88
Outstanding at the end of the period (in dollars per share)	$41.12					$41.12
Cash Units
Non-employee Director Deferred Cash Compensation, Cash Payout Shares
Deferred compensation expense (income) to reflect additional deferrals and change in market value (in dollars)	$2.50					$1.70	($1.60)	$0.70

NET_EARNINGS_ATTRIBUTABLE_TO_T2

NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Net earnings attributable to The Estee Lauder Companies Inc. (in dollars)	$272.10	$213.20	$935.90	$946.40
Denominator:
Weighted-average common shares outstanding - Basic	378.5	385.8	380.1	387.3
Weighted-average common shares outstanding - Diluted	384.7	392.1	386.3	394.1
Net earnings attributable to The Estee Lauder Companies Inc. per common share:
Basic (in dollars per share)	$0.72	$0.55	$2.46	$2.44
Diluted (in dollars per share)	$0.71	$0.54	$2.42	$2.40
Stock options
Denominator:
Incremental common shares attributable to share-based payment arrangements	4.6	4.8	4.6	5
RSUs
Denominator:
Incremental common shares attributable to share-based payment arrangements	1.6	1.2	1.6	1.4
Performance share units based on total stockholder return
Denominator:
Incremental common shares attributable to share-based payment arrangements				0.1
MSU
Denominator:
Incremental common shares attributable to share-based payment arrangements		0.3		0.3

NET_EARNINGS_ATTRIBUTABLE_TO_T3

NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Details 2)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Stock options
Antidilutive Securities Excluded from Computation of Earnings, Per Share
Antidilutive shares excluded from the calculation of diluted earnings per share	2.1	1.8
Contingently Issuable Shares
Antidilutive Securities Excluded from Computation of Earnings, Per Share
Antidilutive shares excluded from the calculation of diluted earnings per share	0.8	0.8

EQUITY_Details

EQUITY (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Increase (Decrease) in Stockholders' Equity
Balance			$3,869.40
Net earnings	272.7	213.7	939.6	950.7
Common stock dividends			-265.4
Other comprehensive income (loss)	-115.7	-3.1	-311.2	48.8
Acquisition of treasury stock			-572.7
Stock-based compensation			205.2
Balance	3,864.90		3,864.90
Total stockholders' equity - The Estee Lauder Companies Inc.
Increase (Decrease) in Stockholders' Equity
Balance			3,854.90
Net earnings			935.9
Common stock dividends			-259.6
Other comprehensive income (loss)			-308.6
Acquisition of treasury stock			-572.7
Stock-based compensation			205.2
Balance	3,855.10		3,855.10
Common stock
Increase (Decrease) in Stockholders' Equity
Balance			5.6
Stock-based compensation			0.1
Balance	5.7		5.7
Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Balance			2,562.70
Stock-based compensation			254
Balance	2,816.70		2,816.70
Retained Earnings
Increase (Decrease) in Stockholders' Equity
Balance			6,265.80
Net earnings			935.9
Common stock dividends			-259.6
Balance	6,942.10		6,942.10
AOCI
Increase (Decrease) in Stockholders' Equity
Balance			-100.3
Other comprehensive income (loss)			-308.6
Balance	-408.9		-408.9
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Balance			-4,878.90
Acquisition of treasury stock			-572.7
Stock-based compensation			-48.9
Balance	-5,500.50		-5,500.50
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity
Balance			14.5
Net earnings			3.7
Common stock dividends			-5.8
Other comprehensive income (loss)			-2.6
Balance	$9.80		$9.80

EQUITY_Details_2

EQUITY (Details 2) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

In Millions, except Per Share data, unless otherwise specified

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Mar. 16, 2015

Feb. 04, 2015

Dec. 15, 2014

Nov. 03, 2014

Sep. 15, 2014

Aug. 14, 2014

4-May-15

Jun. 15, 2015

Class of Stock

Cash dividends declared per common share (in dollars per share)

$0.24

$0.20

$0.68

$0.58

Purchase of Class A Common Stock (in dollars)

$572.70

Common Class A

Class of Stock

Cash dividends declared per common share (in dollars per share)

$0.24

$0.24

$0.20

Dividends paid (in dollars per share)

$0.24

$0.24

$0.20

Purchase of Class A Common Stock (in shares)

8.4

Purchase of Class A Common Stock (in dollars)

$626.10

Common Class A | Subsequent event

Class of Stock

Cash dividends declared per common share (in dollars per share)

$0.24

Common Class A | Subsequent event | Forecast

Class of Stock

Dividends paid (in dollars per share)

$0.24

Common Class B

Class of Stock

Cash dividends declared per common share (in dollars per share)

$0.24

$0.24

$0.20

Dividends paid (in dollars per share)

$0.24

$0.24

$0.20

Class B common stock converted into shares of Class A common stock (in shares)

1.2

Common Class B | Subsequent event

Class of Stock

Cash dividends declared per common share (in dollars per share)

$0.24

Common Class B | Subsequent event | Forecast

Class of Stock

Dividends paid (in dollars per share)

$0.24

EQUITY_Details_3

EQUITY (Details 3) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Changes in AOCI, net of tax by component
Balance at the beginning of the period	($100.30)
OCI before reclassifications	-305.3
Amounts reclassified from AOCI	-3.3
Net current-period OCI	-308.6
Balance at the end of the period	-408.9
Net Unrealized Investment Gain (Loss)
Changes in AOCI, net of tax by component
Balance at the beginning of the period	1.4
OCI before reclassifications	0.6
Amounts reclassified from AOCI	-1
Net current-period OCI	-0.4
Balance at the end of the period	1
Net Derivative Instrument Gain (Loss)
Changes in AOCI, net of tax by component
Balance at the beginning of the period	-0.9
OCI before reclassifications	66.6
Amounts reclassified from AOCI	-14.8
Net current-period OCI	51.8
Balance at the end of the period	50.9
Amounts Included in Net Periodic Benefit Cost
Changes in AOCI, net of tax by component
Balance at the beginning of the period	-233
OCI before reclassifications	20
Amounts reclassified from AOCI	12.5
Net current-period OCI	32.5
Balance at the end of the period	-200.5
Foreign currency translation gains	21
Translation Adjustments
Changes in AOCI, net of tax by component
Balance at the beginning of the period	132.2
OCI before reclassifications	-392.5
Net current-period OCI	-392.5
Balance at the end of the period	($260.30)

EQUITY_Details_4

EQUITY (Details 4) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Reclassification adjustments from accumulated other comprehensive income
Interest income and investment income, net	$3.10	$2.70	$8.50	$6
Cost of sales	-502.9	-498.7	-1,612.60	-1,624.40
Selling, general and administrative	-1,680.40	-1,709.50	-5,265.40	-5,173.90
Interest expense	-15.2	-15	-45	-44.2
Earnings before Income Taxes	385.1	329.3	1,341.50	1,409.20
Benefit (provision) for deferred taxes	-112.4	-115.6	-401.9	-458.5
Net Earnings	272.7	213.7	939.6	950.7
Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income
Net Earnings	5.7	-2.6	3.3	-6.9
Net Unrealized Investment Gain (Loss) | Amount Reclassified from AOCI | Available-for-sale securities
Reclassification adjustments from accumulated other comprehensive income
Interest income and investment income, net			1.5
Benefit (provision) for deferred taxes	-0.1		-0.5
Net Earnings	-0.1		1
Net Derivative Instrument Gain (Loss) | Amount Reclassified from AOCI | Foreign currency forward contracts
Reclassification adjustments from accumulated other comprehensive income
Cost of sales	3.6	1.1	5.4	3.6
Selling, general and administrative	10.5	0.6	17.3	3.3
Earnings before Income Taxes	14.1	1.7	22.7	6.9
Benefit (provision) for deferred taxes	-4.9	-0.5	-8	-2.3
Net Earnings	9.2	1.2	14.7	4.6
Gain (Loss) on Fair-Value Hedges | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income
Benefit (provision) for deferred taxes			-0.1	-0.1
Net Earnings		0.1	0.1	0.1
Gain (Loss) on Fair-Value Hedges | Amount Reclassified from AOCI | Settled interest rate-related derivatives
Reclassification adjustments from accumulated other comprehensive income
Interest expense		0.1	0.2	0.2
Amounts Included in Net Periodic Benefit Cost | Amount Reclassified from AOCI
Reclassification adjustments from accumulated other comprehensive income
Amortization of prior service cost	-0.8	-1.1	-2.6	-3.3
Amortization of actuarial loss	-5.2	-4.4	-16.3	-13
Settlements and curtailments	1.1		1.1
Earnings before Income Taxes	-4.9	-5.5	-17.8	-16.3
Benefit (provision) for deferred taxes	1.5	1.6	5.3	4.7
Net Earnings	($3.40)	($3.90)	($12.50)	($11.60)

STATEMENT_OF_CASH_FLOWS_Detail

STATEMENT OF CASH FLOWS (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash:
Cash paid during the period for interest	$41.30	$41.10
Cash paid during the period for income taxes	317.6	357.6
Non-cash investing and financing activities:
Incremental tax benefit from the exercise of stock options	-8.6	-5.1
Capital lease obligations incurred	7.6	12
Noncontrolling Interests
Non-cash investing and financing activities:
Accrued dividend distribution to noncontrolling interest	$1.40	$2.40

SEGMENT_DATA_AND_RELATED_INFOR2

SEGMENT DATA AND RELATED INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
			segment
Segment Reporting Information
Number of operating segments			1
Net Sales:
Net Sales before adjustments associated with restructuring activities	$2,580.50	$2,549.80	$8,256	$8,243.40
Net Sales	2,580.50	2,549.80	8,256	8,243.50
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	397.2	341.8	1,378	1,445.30
Operating Income	397.2	341.6	1,378	1,447.40
Reconciliation:
Total adjustments associated with restructuring activities		-0.2		2.1
Interest expense	-15.2	-15	-45	-44.2
Interest income and investment income, net	3.1	2.7	8.5	6
Earnings before Income Taxes	385.1	329.3	1,341.50	1,409.20
Sales returns (included in Net Sales)
Reconciliation:
Total adjustments associated with restructuring activities				0.1
The Americas
Net Sales:
Net Sales before adjustments associated with restructuring activities	1,109.90	1,072	3,426.10	3,469
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	109.6	111.5	287.8	419.7
Europe, the Middle East and Africa
Net Sales:
Net Sales before adjustments associated with restructuring activities	950.3	959.4	3,104	3,031.60
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	204.3	160.2	729.4	673.4
Asia/Pacific
Net Sales:
Net Sales before adjustments associated with restructuring activities	520.3	518.4	1,725.90	1,742.80
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	83.3	70.1	360.8	352.2
Skin Care
Net Sales:
Net Sales before adjustments associated with restructuring activities	1,101	1,132.10	3,466.80	3,564.40
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	215.7	179	709.2	758.6
Makeup
Net Sales:
Net Sales before adjustments associated with restructuring activities	1,082.50	1,015.70	3,280	3,145.80
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	159.3	149.9	538.6	564.5
Fragrance
Net Sales:
Net Sales before adjustments associated with restructuring activities	263.2	270.5	1,080.30	1,115.70
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	17.5	-1.9	104	95.5
Hair Care
Net Sales:
Net Sales before adjustments associated with restructuring activities	125.6	120.8	390.8	380.7
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	7.1	13.2	32.1	29.3
Other
Net Sales:
Net Sales before adjustments associated with restructuring activities	8.2	10.7	38.1	36.8
Operating Income (Loss)
Operating Income (Loss) before adjustments associated with restructuring activities	($2.40)	$1.60	($5.90)	($2.60)